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Chapter 1 
Overall Goal and Specific Aims 
1. Introduction
A critical need exists to find alternatives to human organ transplantation.  Due to 
a scarcity of available transplant organs 17 people die every day in the United States 
alone1.  Tissue engineering is a field that seeks to alleviate the transplant crisis using 
biodegradable matrices.  The matrices support and guide the ingrowth of cells while the 
tissue regenerates, and then degrade away leaving only normal healthy tissue.   
Currently a variety of materials are used for tissue engineering including natural, 
animal derived, matrices and synthetic polymer matrices.  One example of a natural 
matrix used in clinical practice is small intestinal submucosa (SIS).  SIS is a dense 
connective tissue harvested from the mamalian small intestine that has shown promise in 
clinical settings2.  However, natural matrices are inherently heterogeneous which creates 
problems with consistency and mass production3.  The problem of heterogeneity inherent 
in natural matrices can be solved by building scaffolds using polymeric materials.  
Current research is searching for a polymer system that has both appropriate biological 
and mechanical properties.   
By using polymers the mechanical properties and degradation time of the scaffold 
can be controlled.  Additionally, standard polymer fabrication techniques can be used to 
generate porous scaffolds with a variety of structures.  There are two major classes of 
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polymers: natural polymers and synthetic polymers.  Natural polymers are derived from a 
variety of sources including fish scales, rat tails, and crab shells.  Natural polymers have 
superior biological properties.  However, they lack mechanical strength.  One natural 
polymer is chitosan, a polysaccharide derived from N-deacetylation of chitin, a polymer 
present in the outer shells of crustaceans.  Chitosan has been widely investigated in 
wound dressing and drug delivery systems 4, and will support biological activity in 
diverse cell types5.  Synthetic polymers such as poly (lactic acid) (PLA), poly (glycolic 
acid) (PGA), and their copolymers (PLGA, PLLA, etc) 6-12 have generated immense 
interest as tissue engineering materials owing to their widespread use in a variety of 
biological applications for more than three decades and their strong FDA approval  
history 13.   
Recent developments in tissue engineering have shown that the 3D porous 
architecture plays an important role by guiding colonization of cells and subsequent 
regeneration 14. Both structural properties such as pore size, porosity, and topography and 
biochemical properties such as surface charge, chemical composition, and cellular 
binding domains affect tissue regeneration.  Mechanical stimulation and cellular 
signaling also direct the colonization, proliferation, and differentiation of cells in the 
porous matrix during regeneration 15.  Various technologies have been developed to 
generate porous matrices from a variety of polymers.  For example, one method for 
combining the two polymer systems involves fabricating a composite structure using both 
natural and synthetic polymers, one to provide mechanical strength and another to 
provide biological activity16.  While a fundamental understanding of the various factors 
that go into the design of the porous materials have been studied, it is important to 
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determine the major processes that occure during tissue regeneration.  The transient 
changes in the porous material are not well understood, especially in regenerating large 
sections of tissue required for applicatios such as skin, bladder, and cartilage. 
An important aspect of scaffold design is oxygen and nutrient transport through 
the porous structure.  Before new microvasculature has formed, cells within the scaffold 
are dependant upon the transport of oxygen for survival.  Therefore it is important to 
study the oxygen transport across the scaffold.  There are several possible ways to grow 
cells within the scaffold.  Standard cell culture practice calls for cell to be grown in batch 
culture on flat, stationary plates.  While this method has been successfully used for years, 
the cells will only form a monolayer making it difficult to propogate large numbers of 
cells.  Batch culture systems also introduce a transient element to the system.  The 
concentration of nutrients and waste products changes over time.  The transient aspects 
can be removed by using a continuous flow system.  Perfusion reactors provide a 
constant flow of media to the scaffold.  Because they are continuous flow reactors, the 
concentration of nutrients, signaling molecules, and waste products can be more 
effectively controlled.  Bioreactors have been designed to encourage 3D cell growth and 
colonization.  Several bioreactor types have been designed to grow functional 3D tissue 
engineering scaffolds 17.  However, most of the previous work uses very small samples 
that are not suitable for regenerating large sections of tissue required for applicatios such 
as skin, bladder, and cartilage.  Hence, a better fundamental understanding of tissue 
regeneration in such high aspect ratio (large size to very small thickness) systems is 
required.  
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Natural matrices contain growth factors and other signaling molecules important 
for tissue regeneration.  However, synthetic polymers lack cellular signaling molecules 
important to tissue regeneration.  Another method to improve tissue regeneration is to 
incorporate a controlled release particle system into the polymer scaffold in order to 
regulate cellular signals.  The controlled release system will also create local scale 
transport barriers in the matrix.  Therefore, the particles embedded in the porous matrix 
could be used to tailor the properties of for specific applications. 
Another key development in bioreactor design is the use of mechanical forces to 
aid tissue development.  Some native tissues regenerate better under the influence of 
mechanical forces.  Therefore, tissue regeneration can be encouraged by including 
changes in the mechanical force experienced by the scaffold.  One easy way to vary the 
mechanical loading in a reactor is to change the pressure.   
The mechanical reinforcement utilized in composite scaffolds creates transport 
barriers within the system.  On a macro level these barriers could lead to a disruption in 
the flow distribution and cause dead spots (areas with low flowrates) that are not 
desirable in tissue engineering bioreactors.  Additionally, changes within the porous 
structure during fabrication or tissue regeneration can affect both the pressure drop across 
the matrix and the shear stresses within the matrix.  Therefore, a better understanding and 
control of the flow phenomena within the porous matrix should enable improved scaffold 
designs and consequently improved tissue regeneration. 
The purpose of this study was to understand the transport properties within high 
aspect ratio polymer matrices for the purposes of improving the design of synthetic tissue 
engineering scaffolds.  The underlying hypothesis being that incorporation of a 
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nanoparticle controlled release system into composite polymer scaffolds will enable the 
cellular microenvironment to be modified for specific applications in tissue regeneration.  
Further, studying oxygen transport within the scaffold in order to better control flow 
distribution, shear stresses, and pressure drop within the material is important to improve 
the quality of the regenerated tissue.  This work helps in defining basic engineering 
principles in mass transport processes during tissue regeneration, and enabling the design 
of improved bioreactors, giving hope to the patients on the waiting list and their families. 
Specific Aim 1:  Understand the use of nanoparticles for local delivery of signaling 
molecules within porous structures. 
This portion of the study aimed to examine the influence of localizing 
nanoparticles on the mass transport of nutrients through porous scaffolds.  Nanoparticles 
can be used to deliver proteins important in cell signaling.  The end goal is to develop a 
delivery system for signaling molecules in order to improve the regenerative effects of 
synthetic scaffolds while retaining their controllable physical properties.  Nanoparticles 
from both synthetic (PLGA) and natural polymers (chitosan) were synthesized.  These 
particles were incorporated at various densities into the composite scaffold and small 
intestinal submucosa, a natural matrix.  Then, the effect of the particles on the scaffold’s 
mass transfer properties was measured based on the permeability of the matrix to urea 
both before and after modification.  In addition, changes in biophysical properties and 
microstructure were assessed.   
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Specific Aim 2: Modeling fluid flow through porous scaffolds  
Flow within bioreactors containing large porous structures with high aspect ratios 
has not been studied.  Non-uniform flow patterns lead to i) poor distribution of nutrients 
and ii) non-uniform shear stress distribution.  These factors affect cellular colonization 
and the assembly of extracellular matrix elements which affect the quality of regenerated 
tissues.  Further, porous characteristics change during tissue regeneration affecting mass 
transport.  There are two basic ways to change the scaffold’s porous structure, during 
fabrication (where the number of pores for a given area is tied to the pore diameter) and 
during regeneration (where the cells grow in reducing the pore diameter but leaving the 
number of pores per area constant).  Hence, one has to understand the fluid distribution 
and the effect of shape of the reactor.   
The non-ideal fluid distribution is characterized using the residence time 
distribution (RTD).  The RTD measures the amount of time different molecules present 
in the fluid spend within the reactor.  In other words, the RTD is a measure of dispersal of 
a molecule in a flowing medium owing to the combined action of a velocity profile and 
molecular diffusion.  Understanding these characteristics is important in designing the 
reactor shape and optimizing the location of the inlets and outlets.  This study utilized a 
well understood parallel plate reactor and evaluated the effect of porous structure in the 
flow domain.  A parallel plate reactor with three different inlet and outlet conditions was 
simulated using CFD packages CFX 11 (ANSYS Inc, Canonsburg, PA.) and/or Comsol 
Multiphysics 3.4 (COMSOL, Inc., Burlington, MA).  Additionally, the effect of the 
scaffold’s porous structure on both shear stress and pressure drop within the scaffold 
were investigated using the COMSOL software.  Simulations were performed to 
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investigate the effect of changing the porous structure on shear stress and pressure drop 
within the matrix.  Further experiments were performed to validate the simulation results.   
Specific Aim 3: Modeling transport and consumption of oxygen through cell seeded 
scaffolds. 
One cause of poor quality of regenerated tissue is hypoxia, a lack of oxygen in the 
center of the scaffold.  Modeling oxygen transport in a cell seeded tissue engineering 
construct requires that the effects of cellular respiration be included.  In order to combat 
this problem a computer model was developed to visualize the transport of oxygen 
through the porous scaffold.  Cellular oxygen consumption was calculated using rate data 
available in the literature.  The consumption of oxygen was included into the simulations 
using the chemical reaction capabilities of the COMSOL Multiphysics software.  
Simulation data for both chondrocytes and smooth muscle cells was used to determine a 
range of flowrates where the oxygen profile may be visualized using a coated glass slide 
where the coating’s fluorescence is quenched by oxygen.   
Further, attempts were made to validate the model using bioreactor experiments 
similar to Specific Aim 2.  A benchtop optical system containing the same geometry of 
bioreactor as the computational model was constructed.  Oxygen concentration was 
measured using oxygen to quench the florescence of a ruthenium compound.  The top of 
the reactor was a glass slide coated with ruthenium, and the oxygen profile was 
visualized.  Using this technique data from the CFD model can be verified, but future 
research is needed visualize the oxygen profile experimentally. 
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Chapter 2: 
Porous Materials and Material Properties 
2.1 Tissue Engineering Basics 
The basic approach of tissue engineering uses biodegradable scaffolds to support 
and guide the in-growth of cells.  Cells are seeded on a degradable porous structure.  The 
cells colonize the material and proliferate, filling the scaffold structure as it degrades 
away. Eventually, the scaffold material degrades away leaving only normal healthy 
tissue18-20 (Figure 1).   
Cells
Porous 
Scaffold
Bioactive
groups
Mature 
and 
Implant
Normal 
Healthy 
Tissue
 
Figure 1. Concept of Tissue Engineering 
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The scaffold must provide enough mechanical strength to withstand physiological 
stresses, must provide an environment suitable for cellular growth, and should contain 
suitable biological properties to support cellular attachment, proliferation, and 
differentiation.  Porous structures being used as degradable scaffolds should have the 
following basic properties.  The scaffolds should be:  
(1) biocompatible, bioresorbable, and biodegradable during tissue regeneration 
process. 
(2) porous with an interconnected network to enable rapid tissue ingrowth through 
pores, and to allow unimpaired diffusion of nutrients, oxygen and wastes.  
(3) able to support cell attachment, proliferation, and differentiation, as well as 
have suitable surface properties (wettability, stiffness, and compliance). 
(4) mechanically strong, able to withstand stresses at the site of implantation. 
(5) biodegradable with biocompatible, non-toxic, and removable degradation 
products.   
Scaffolds generated from natural polymers 21, synthetic polymers22, or by removing the 
cellular components from xenogeneic tissues 23 have been used with and without prior 
cell-seeding to support and guide the in-growth of cells.  The unseeded techniques 
involve the direct in vivo implantation of a biodegradable scaffold into the body, allowing 
the natural process of regeneration to occur.  In contrast, seeded techniques utilize in vitro 
cell culture on biodegradable scaffolds to establish cell-composite grafts, followed by in 
vivo implantation of the grafts.   
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2.2 State of the Art: Natural Matrices  
One option for creating tissue scaffolds is to use extracellular matrix (ECM) 
components derived from animal sources.  For example porcine acellular dermis has been 
used for skin regeneration24 and control of hypertrophic scarring 25.  The human umbilical 
vein, a portion of the umbilical cord that is typically discarded, has been used for 
engineering blood vessels and vasculature 26, 27.  Additionally, decellularized scaffolds 
derived from porcine heart valves28, human pericardium29, and whole rat hearts30 have 
been used for cardiac tissue engineering.  For more information, a thorough review of 
natural matrices has been written by Badylak.31 
One natural matrix of particular interest is small intestinal submucosa (SIS).  SIS 
has shown significant success in various tissue engineering applications32.  SIS is a dense 
connective tissue harvested from the small intestine.  SIS is obtained after removing the 
mucosa, serosa, and muscle layers from the harvested tissue (Figure 2).   
 
 
Figure 2.  Layers within the Small Intestine 
 
Mucosa 
Submucosa 
Muscle Layer 
Serosa 
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Porcine SIS has generated immense interest in various tissue engineering 
applications due to its diverse favorable properties 33, 34.  SIS does not require cell seeding 
prior to in vivo implantation for bladder regeneration2.  SIS is rich in type 1 collagen, 
biocompatible, pliable, and resistant to infection.  Additionally, SIS has a resorption rate 
of 4-16 weeks 35, 36 and its immune response shows a phenotypic characteristic of tissue 
remodeling rather than rejection 37.   SIS promotes cell migration of numerous cell types 
and has been tested for regeneration of diverse tissues including large vascular grafts 38, 
venous valves and leaflets 39-41, skin 42, tendons 43, and wound dressing 44.  For urinary 
tract reconstruction, SIS has been used for bladder augmentation 45-47, for ureter 48 and 
urethra 45, 49 replacement, and to promote regeneration of transitional epithelium, smooth 
muscle, and peripheral nerves with no evidence of immunological rejection 50.  Long-
term studies show that SIS grafts can be remolded and replaced by the host and such 
regenerated tissues become histologically indistinguishable from native tissues 46.  The 
remodeled tissue shows complete regeneration of all three layers (mucosa, smooth 
muscle, and serosa) of the bladder in rat 51 and dog 52, 53 models with only problem being 
low quality and disorganized smooth muscle fibers.   
However, large-scale preparation of SIS is hindered by various physiochemical 
properties which affect the quality and reliability of the tissue regeneration in clinical 
settings.  A number of trials have clearly demonstrated that not all SIS materials are the 
same47, 54-56.  Investigations indicate that SIS from older pigs (>3yrs) is superior in 
regards to bladder regeneration than SIS from younger pigs (<8 months),  multi-ply SIS 
(4 layer) does not produce reliable bladder regeneration compared to single-ply SIS, 
machine and hand-made SIS have similar outcomes,  E-beam sterilization results in 
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severe contraction and bone formation within the graft in addition to increased graft 
contraction relative to SIS prepared by ethylene oxide (used in commercial preparations) 
or peracetic acid, and the physical and mechanical characteristics of the matrix, such as 
permeability, thickness, tensile properties, fatigue properties, and ultrastructural 
properties, vary depending on the age of the animal, the sterilization technique, and the 
location within the small intestine it is harvested from.3.  Distal SIS demonstrated the 
most desirable tissue regeneration.  In a canine model study, bladder augmentation with 
distal SIS showed remarkably enhanced bladder regeneration relative to proximal SIS 57.  
Further, SIS obtained from the distal of the intestine enables better cellular ingrowth and 
tissue remodeling than SIS taken from the proximal region 2.  Thus, forming synthetic 
matrices with physiochemical properties similar to distal SIS will be useful in bladder 
and other soft tissue regeneration.   
2.3. Formation of Three Dimensional Polymer Scaffolds  
One way to overcome the heterogeneity in natural matrices uses polymers to 
fabricate degradable 3D porous matrices.  Several techniques have been developed to 
fabricate porous scaffolds, including solvent casting/particulate leaching 58, fiber bonding 
(unwoven meshes) 59, gas foaming 60, and phase separation/emulsification 61.  Another 
method to fabricate porous scaffolds is to introduce a porogen such as salt (NaCl) into the 
polymer and then remove it with a solvent (particulate leaching) 62.  The leaching of salt 
from a polymer composite can form pores within scaffolds, the pore sizes are dependent 
on the size and amount of salt crystals.  Pore size and distribution is difficult to control.  
Gas porogen has been used as alternative to eliminate the use of organic solvents (gas 
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foaming).  But the pores created in this method are non-uniform, limiting cell seeding and 
migration 59.   
Scaffolds can be formed using 3D printing techniques63.  Scaffolds are built layer 
by layer, and the pore size and spacing are controlled by the pattern used. The advantage 
to 3D printing is the control of pore size and distribution. The disadvantage is that the 
fiber diameter limits the pore sizes and configurations possible.  Currently, construction 
is limited to a 150 µm fiber diameter 64.  Direct writing processes are also limited by the 
ink used.  To assure successful printing the ink must be viscous enough to holds its shape 
after printing but not so viscous that it is too difficult to pump.  Additionally the ink must 
quickly form the polymer fiber after printing, as well as bond to previously printed layers.      
3D porous scaffolds can also be created using standard microfabrication 
techniques65 including microembossing66 and soft lithography67, 68.   Microfabricated 
scaffolds can be produced that contain both pores and nano-scale surface features, 
enabling better control of the cellular microenvironment. 
Scaffolds with nanofibers can be produced using electrospinning process69,70, 71.   
In the process of electrospinning a non-woven matrix is formed by directing a charged 
polymer solution at an oppositely charged collector.  Additionally, changing the 
orientation of the collector can produce both random and aligned nanofibers 
arrangements, and multiple nozzles can be used to more carefully control the distribution 
of fibers. 
Three dimensional scaffolds can also be formed using hydrogels, water soluble 
polymers crosslinked into a 3D matrix72.  One of the prime advantages to hydrogels is 
that they can be polymerized in situ by thermo-gelling73 or photocrosslinking 74, 75.  
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Another advantage is that cells can be encapsulated directly into the scaffold, providing 
faster tissue ingrowth.  In autoimmune disorders, like diabetes, hydrogels can serve as a 
protective barrier between the implanted functional cells and the immune system 76. 
Due to a number of advantages this research utilizes controlled rate freezing and 
lyophilization  to create the porous chitosan structures 77.  By controlling the rate of 
freezing, ice crystals form in the solution following the path of heat flow.  While the 
solution freezes the polymer precipitates out of solution and is trapped between the ice 
crystals.  The solvent is then removed by freeze drying, leaving the porous polymer 
structure intact.  The pore size is determined by the size of the ice crystals.  Therefore, the 
size and orientation of pores can be directed by controlling the rate and direction of 
freezing.  By freezing at a constant temperature the pore size becomes a function of 
freezer temperature; quicker freezing will produce smaller pores.  This process also 
avoids heat denaturation of biological materials because it is performed at low 
temperature.  This allows bioactive molecules to be included in the scaffold without 
altering their activity, if necessary. 
2.4 2D vs. 3D Cell Culture 
Many of the cell culture experiments performed in molecular biology are 
cultivated on two-dimensional (2D) tissue culture treated surfaces.  Many in vitro 
experiments have shown that cells have different responses in colonization, proliferation, 
and differentiation on 3D scaffolds than on traditional 2D-tissue culture.  In 2D substrata, 
cultured cells are restricted to spread and attach to a flat rigid glass or tissue culture 
plastic surface (Figure 3).  Hence, biophysical properties of the matrix that provide 
spatio-temporal effects in the body are not present in 2D culture.  However, biophysical 
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properties significantly influence cell adhesion and functions in three-dimensional (3D) 
environment 14.  3D matrices provide physical cues to guide cell colonization as well as 
chemical cues of cell-binding sites to support cell attachment and spreading. Tissue 
engineering has given promise for generating functionally replaceable 3D tissue parts, 
although currently the products obtainable are limited to avascular regions.  
Biodegradable scaffolds are used to support and guide the in-growth of cells i.e., they 
form the template for cell colonization.  Scaffolding material eventually disappears 
leaving only the necessary healthy tissue in a topologically required form 18, 20, 78.  The 
3D matrix provides more space for cellular colonization and proliferation as well as 
provides a different set of physiological signals to the developing tissue.   
2D 3D
 
Figure 3. 2D and 3D Cell Culture 
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2.5 Importance of 3D Spatial Architecture 
It is important to learn what scaffold properties most affect cellular colonization 
and ingrowth because there are a wide variety of methods to fabricate degradable porous 
structures.  As mentioned earlier, cells respond differently in 2D and 3D culture as a 
result of both the 3D porous structure as well as surface properties.  The influence of 
spatial architecture of the porous matrix has been explored in various experiments.  These 
studies 18, 78 have shown in addition to chemical cues and surface properties, 3D matrix 
physical properties such as stiffness,79 hydrophilicity, porosity,80 pore size and void 
fraction 81, 82 can affect cell morphology, attachment, and function (Figure 4).  Especially 
the spatial structures or the topography of scaffolds influence neuron alignment, 
orientation,83 multicellular organization,81 endothelial cell spreading84 and microvascular 
epithelial cell attachment.82  2D surface features such as edges, grooves, steps, roughness 
and pores of substratum significantly influence cell behavior.83, 85   
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Figure 4. Factors influencing colonization in 3D 
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Important structural properties include both the mechanical properties inherent in 
the material, such as break stress, modulus of elasticity, and stiffness, but also the 
properties of the scaffold’s 3D architecture.86  Both the microscale properties experienced 
by the cells and the bulk material properties that provide physical support for both the 
scaffold and the surrounding tissue become important during tissue regeneration.  The 
major architecture features discussed below include porosity, pore size, fiber orientation, 
pore interconnectivity, topography, and scaffold stiffness.   
2.5.1 Porosity 
A highly porous scaffold (>90% porosity) is desirable, since it can support the 
growth of tissue for the necessary nutrients transport87, 88.  Porosity is a measure of the 
open pore volume within the matrix, often called the void fraction.  Mathematically, 
porosity is defined as follows: 
Open Pore VolumePorosity=
Total Volume
      (1) 
Several pore types are possible within a porous matrix (Figure 5).  Open pores 
have cellular access on both sides and allow for liquid flow and transport of nutrients 
through the porous matrix.  Partially open pores are accessible on one side.  They allow 
access for cell colonization, but mass transport of nutrients and waste products is limited 
to diffusion.  Closed pores have no openings and are not accessible by cells.  Other issues 
that complicate porosity are pore tortuosity and heterogeneous pore diameters. 
Consequently, materials for tissue engineering materials concentrate on creating an open 
pore architecture. 
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Figure 5. Types of Pores within the scaffold matrix 
Porosity also plays an important role in regulating cell adhesion and migration.  
High porosity provides a high surface area for cell-matrix interactions, sufficient space 
for ECM regeneration, uniform and efficient cell seeding.89  Higher porosity could also 
lead to increased cell adhesion.90  Pore interconnectivity increases the overall surface area 
for cell attachment and facilitates cell ingrowth in the scaffolds.  Increased 
interconnectivity and porosity also affect the deposition of ECM elements.91 
A functional approach to compare porous structures in a variety of materials is 
through their mass transport properties, such as permeability.  The method of Raghavan 
et al. is one way to determine the permeability of the matrix,3 quasi steady-state transport 
between two sealed chambers is assumed and the following equation is used: 
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      (2) 
where C1 is the initial concentration of the compound of interest, C2 is the concentration 
of the compound of interest at time t. Am is the area of the matrix normal to the mass flux, 
V is the volume of the test chamber, , and P is the permeability.   Permeability is related 
to the diffusion coefficient by 
 
L
D
P m
φ
=         (3) 
where Dm is the diffusion coefficient, φ  is the partition coefficient, L is the thickness of 
the membrane. 
2.5.2 Pore Size.  
There are a variety of ways to fabricate porous materials, but there are three key 
methods. Porous matrices may be derived from heterogeneous natural matrices, by 
forming void spaces within a polymer, or by creating a layered bed of polymer fibers 
(Figure 6).  One method for generating scaffolds uses a two phase polymer/porogen 
system where the porogen is subsequently removed, leaving a system of interconnected 
pores.  The pores can be aligned by controlling porogen formation or alignment.  
Example of this technique are controlled rate freezing and lyophilization (CRFLT)77 and 
salt leaching.92  In CRFLT the pore alignment is controlled using the rate and direction of 
heat transfer.77, 93  Creating a uniform pore size and distribution is a common problem 
when working with porous 3D matrices.  Firstly, the porous structure is usually formed in 
an asymmetric fashion.  Non-spherical pores form where one axis is much longer than the 
other.  The spatial arrangement of pores within the material may also be an issue.  For 
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example, in scaffolds frozen at constant temperature pores are formed in the direction of 
heat transfer.  If a sample insulated on one side and placed in a freezer then areas near the 
surface of the scaffold (exposed to cold air) will freeze faster than areas deeper within the 
scaffold.  The faster rate of freezing near the surface causes small ice crystals (and thus 
smaller pores) to be formed near the top edge of the scaffold material.   
 
Figure 6. Types of porous polymer structures. 
A) Heterogeneous structures, porcine SIS.  B) Pore based structures, freeze dried 
chitosan scaffolds. C) Fiber based structures, poly (glycolic acid) mesh 
 
Pore size refers to the distance between solid sections of the porous matrix.  Pore 
size is typically reported as the diameter of circular pores or the major axis for 
noncircular pores.  Pore size affects cell binding, migration, depth of cellular in-growth, 
cell morphology and phenotypic expression.94  Importantly, appropriate pore size 
provides structural advantages to allow cells to spread into the pores through “bridges” 
from adjacent cells.  There is an “optimum size range” for supporting cell ingrowth.  
Outside this range, cells fail to spread and form networks.  The optimal pore size range 
depends on the materials as well as cell types.95  Many mature cell types including 
endothelial cells (ECs) are unable to completely colonize scaffolds with the pore sizes 
>300 µm due to the difficulty in crossing large bridging distances.96-100  An “optimum 
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pore size range” for supporting cell ingrowth for majority of the mature cell types (except 
osteoblasts and osteocytes) is in the range of 100 -150 µm.96  Recently, it was shown that 
gelatin-chitosan scaffolds (3:1) with 50-80 µm pore size diminished the viability of 
fibroblasts and ECs, relative to 100 to 150 µm pore size chitosan scaffolds.5  Pore sizes 
not only affect cell growth, but also affect scaffolds properties.  For example, the 
elasticity of microporous scaffolds increases as the number of pores within the scaffold 
increases.101   
2.5.3 Fiber Thickness. 
The matrix may also be characterized based on the microscale thickness of the 
individual material fibers.  In some cases where the material is formed from a bed of 
stacked fibers fiber thickness is characterized as the diameter of the individual fibers.  
The fibers may be distributed randomly, as in electrospinning 69-71 or form a highly 
organized system with regular repeating pore units, as in solid freeform fabrication.102  
Thus the fiber thickness, length, width and shape (circular rectangular, etc) must be 
evaluated.  However, defining fiber thickness may not be suitable when pores are formed 
by CRFLT and salt leaching technique.  Utilizing freeze dried scaffolds the material 
forms an interconnected series of planes that connect the pores.   
Fiber orientation within a scaffold affects cell colonization.  Scaffolds made of 
oriented polycaprolactone nanofibers (700 nm in diameter) were found to promote 
phenotypic differentiation of chondrocytes compared with 2D nonporous membranes.70  
Cells seeded on oriented fibrous structures tended to maintain phenotypic shape and had 
guided growth according to nanofiber orientation.  Another study showed that 
significantly more collagen was synthesized by fibroblasts on aligned nanofibers than 
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randomly orientated fibers despite similar proliferation.71  A hypothesis is that spindle-
shaped and oriented fibroblasts in the direction of aligned fibers mimic in vivo condition 
better and thus produce more ECM.  Further studies are necessary to understand the 
mechanisms involved in these cell-matrix and cell-cell interactions. 
2.5.4 Topography. 
The surface characteristics of scaffold materials can be described by their 
topography, micro to nano-scale material surface features.  Topography of scaffold 
surface influences spreading characteristics and activity of cells.103  The existence of 
grooves may inhibit cell movement to bend its cytoskeleton 104 or reshape its actin 
filaments to adjust to the new topography.105  Curtis proposed a term “topographic 
reaction” to describe that cells react as a response to substratum in microscale through 
changes in cell orientation, motility, and adhesion.85  Surface roughness can significantly 
increase cell migration area.106  Nanometer scale roughness has been shown to improve 
the adhesion and growth of both smooth muscle cells107 and chondrocytes108 on polymer 
scaffolds.  However, the mechanisms for enhanced cell behavior are not completely 
understood.  Additionally, the porous structure may be modified post fabrication by 
inclusion of nanoparticles109 or etching the surface of the matrix.107   
Altered surface texture and charge could also affect cell spreading.14, 107  In a 
separate study, antibacterial chitosan was blended with PCL and showed that blending 
compromises the antibacterial property of the material.110, 111  Further, the blend 
membranes showed better support for fibroblast spreading and proliferation.  Surface 
roughness analysis of blend membranes showed significant increase in roughness relative 
to chitosan membranes, and observed antibacterial activity could be partially attributed to 
 23 
changed topography.  Nevertheless, decreased antibacterial activity could also be due to 
altered surface charge distribution.  Additionally, colonization and proliferation of 
mammalian cells may be affected by altering the charge distribution within the porous 
structure.112 
2.6. Cellular Interaction 
2.6.1. Changes in Cell-Adhesion.   
An important part of cell colonization is cell signaling.  Cellular adhesion, 
proliferation, and differentiation can be modified using specific signaling molecules, such 
as growth or differentiation factors.  The presence of specific cellular binding sites 
greatly enhances cell adhesion.  The proliferation and differentiation of various cell types 
may be controlled by incorporating signaling molecules into the tissue engineering 
matrix.   
To incorporate bioregulation of matrix elements, grafting a small peptide 
Arginine-Glycine-Aspartic acid (RGD) onto polymers is an approach taken by many 
investigators.113  The use of RGD is based on the understanding that the majority of 
communication across the cell wall takes place via integrins, which communicate with 
many matrix elements through the RGD binding domain.  Additionally, materials such as 
collagens, glycosaminoglycans (GAGs) and their analogues (eg. Dextran sulfate) can be 
incorporated into the scaffold structure in order to direct cellular growth and provide 
binding sites.113,112  Our group has previously shown that the presence of binding sites 
improves cellular adhesion.  Endothelial cells were grown on films of chitosan, gelatin or 
a blend of the two and then subjected to shear stresses similar to those present in arteries 
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or veins for three hours.  Cells remained attached to the blends containing gelatin, but no 
cells were found adhered to the pure chitosan film.14  
Bioregulation of the porous matrix can also be achieved by the incorporation of 
growth factors.  For example growth factors such as vascular endothelial growth factor 
(VEGF) 116 and basic fibroblast growth factor (bFGF)114, 115 as well as ECM components 
such as fibronectin116 are important in angiogenesis.  Growth factors are typically 
proteins with short half-lives.  Therefore, a controlled release system is needed in order to 
protect the growth factors and provide a sustained signal.  Cells will also receive signals 
from other cells within their vicinity.  Therefore, various co-culture techniques allow 
communication between multiple cell types.117   
Many cell types such as fibroblasts, mesenchymal stem cells, epithelial cells, and 
neural crest cells show different adhesions when grown on 3D matrices as opposed to 2D 
cell culture.118-120  A possible reason is that the 3D architecture could distribute binding 
sites in a variety of special locations rather than on only the single plane of rigid substrate 
as in traditional 2D architecture.120, 121  Cells may have cytoskeletal adaptor proteins on 
3D matrix in addition to proteins present in 2D focal adhesions.120, 122  For example, focal 
adhesion kinase (FAK) in 3D matrix adhesion is poorly phosphorylated at its major 
tyrosine phosphorylation site for cell adhesion.  Such differences in cell adhesion 
between 2D and 3D matrices lead to different signal transduction and subsequent 
alteration in cellular rearrangement. 
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2.6.2. Mechanotransduction. 
The mechanical forces a scaffold is subjected to during tissue regeneration should 
also be accounted for during cell colonization.  Studies have shown that both 
hydrodynamic stresses 5, 123 and mechanical stresses124 affect cell colonization.  For 
example, endothelial cells5 and chondrocytes125 grown in a perfusion reactor align cells in 
the direction of flow.  Beyond the structural modifications, shear stress initiates a number 
of signal transduction cascades leading to altered gene expression profiles and functional 
changes, particularly in endothelial cells 126.  In vitro studies have shown that shear stress 
activates mitogen-activated protein (MAP) kinases (including extracellular signal 
regulated kinase and c-Jun N-terminal kinase ) 127-129, and kinases involved in focal 
adhesion such as FAKs, Src family kinases, and phosphatidylinositol 3-kinase 130.  
Mechanical forces affect cells in a variety of ways including opening or closing ion 
channels (changing mass transport properties across the cell membrane) and unfolding 
selected protein domains (providing access to a different set of binding sites.) 131   
Flow through the scaffold microarchitecture dictates the local shear stress rates 
experienced by the cells.  Further the scaffold architecture controls the transport of 
nutrients within the samples.  Channeling and other flow irregularities can result in local 
hypoxia or extracellular matrix washout.131  The presence of flow within a reactor also 
affects the production of ECM elements, for example rat bone marrow cells produce 
greater mineralization in scaffolds under direct perfusion.132   
Once the scaffold is placed into a flow system (either implanted in vivo or grown 
in vitro in a bioreactor) the effect of loading from both external forces and fluid flow can 
affect cell colonization.   While the scaffold itself will be subjected to the bulk forces 
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supplied by the tissue and fluid flow, the cells will experience the micromechanical 
properties of the individual fibers and local shear stresses within the porous structure 
(Figure 7). The cell senses both the porous structure and other cells near where it is 
attached.  An important step in characterizing the porous structure is to examine 
microenvironment surrounding the cells.   
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Figure 7. Micromechanical forces acting on a single cell in a porous structure 
 
Cellular activity is influenced by the stiffness of the substrate.133-135  Stiffness is 
the resistance of the material to deformation, typically reported in force per distance.  It is 
the slope of the load - extension curve.  The dimensionality may be removed from the 
stiffness calculation by using the modulus of elasticity.  The modulus of elasticity is the 
initial slope of the stress – strain curve.  However, the thickness of the material must be 
measured to calculate the modulus of elasticity, and the thickness measurement becomes 
a major source of error when measuring very small thicknesses.  The bulk stiffness 
controls the overall deformation of the matrix while each individual cell will encounter 
the stiffness of the individual fibers during colonization.  Cells show reduced spreading 
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and disassembly of actin even when soluble adhesive ligands are present in weak gels.136, 
137
  This could be via the response of tractional forces between cells and materials; 
scaffold should be able to withstand cell contractile forces.135  Maximum tractional force 
generated by a cell could be as much as 10-15% of substrate modulus.136   
In an effort to develop anti-scarring therapies in wound healing, understanding the 
process of increased collagen packing has been extensively investigated 138, 139.  A variety 
of cell- or matrix- based continuum modeling has also been attempted.140, 141  It is very 
well established that fibroblasts hug the collagen fiber and induce tractional forces.  The 
developed tractional forces lead to the generation of contractile forces which are essential 
for alignment of collagen fibers and tissue healing.  Thus, one of the approaches to 
minimize scarring is to increase the tensile strength via wound dressing materials.  3D 
collagen sponges have been used alone 142, 143 or in conjunction with basic fibroblast 
growth factor,144 fibronectin, or hyaluronic acid.145  Exogenous collagen increased wound 
tensile strength and increased degree of reepithelialization i.e., early dermal and 
epidermal wound healing.  Further, hyaluronic acid and fibronectin may also be involved 
in faster wound healing via helping the migration of fibroblasts.146  However, it is not 
clear whether these treatments reduced scarring in the long term.  Nevertheless, the 
rigidity of the scaffold affect the formation of extracellular matrix which affect cellular 
activity.119   
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2.7. Matrix Turnover. 
Cell colonization also involves the deposition of extracellular matrix elements.  
Cells can synthesize extracellular matrix components in response to different physical 
and chemical signals from surrounding 3D matrix.  Unlike 2D architecture the 
degradation of a 3D matrix can create more space for cell expansion and migration.  
Scaffold degradation rate should be synchronized with the cell growth rate to ensure no 
space restriction due to slow degradation rate or the loss of structural support due to 
faster degradation.  Key factors include the mode of degradation.  For example, synthetic 
polyesters are hydrolytically degraded;22 therefore, they will begin to break down if they 
are not protected from moisture.  Conversely, natural polymers, such as chitosan, are 
enzymatically degraded and can be stored in hydrated condition.77  Dynamic changes 
during the degradation process must also be accounted for.  Some materials (hydrogels) 
can swell several times their dry weight.147  It has also been shown that cellular constructs 
grown in vitro will shrink, possibly as a result of cellular attachment and contraction or as 
a result of hydrodynamic forces compressing the scaffold.  The molecular weight of a 
polymer will also change over the course of degradation.  Amorphous 50:50 PLGA 
shows an 80% drop in molecular weight over the course of eight weeks which reduces 
the polymer’s tensile break stress by 75%.16  Another positive aspect of degradable 
polymer systems is that they can also be used for the controlled release of bioactive 
molecules.  Degradable polymers have been used for drug delivery for years.  Recently 
they have been used to deliver growth and differentiation factors within tissue 
scaffolds.148 
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Matrix turnover significantly influences cellular phenotypic characters which in 
turn alters assembly of de novo synthesized matrix elements.  Tissue remodeling in a 
variety of patho/ physiological processes including embryogenesis,149 normal tissue 
development, cancer,150 and wound healing 151, 152 has been evaluated.  These studies 
implicate an array of molecules regulating the process which are regulated at 
transcriptional, translational and post-translation levels.  Matrix metalloproteinases 
(MMP) form a degradative enzyme family with at least 20 members.  MMPs mediate 
degradation of essentially all components of the ECM.153  Loss of GAGs in arthritic 
patients has been attributed to the increased production of stromelysin (MMP-3).154  
Gelatin turnover is mediated either by MMP-2 (Gelatinase A), a constitutively produced 
homeostatic enzyme, or by MMP-9 (gelatinase B),155 and upregulated in acute and 
chronic inflammations.  MMP expressions are regulated by soluble mediators, presence 
of substrates, matrix elements,156 and adhesive interactions.157  In turn, MMPs influence 
rate of matrix synthesis.  For example, cells exposed to hydrogels containing MMP-
specific peptides show an increase in the transcriptional activity of collagen and 
proteoglycan synthesis.158  In addition, αVβ3 can bind to MMP-2,
157
 in an RGD-
independent way, thereby localizing MMP-2-mediated matrix degradation to the 
endothelial cell surface.159  
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2.8 Summary 
In summary, there are a variety of natural matrices available for tissue 
engineering.  Unfortunatly, the heterogeneous nature of natural matrices (such as SIS) 
leads to inconsistent regeneration.  One method to improve the consistency of 
regeneration is to fabricate a degradable porous matrix from polymers.  It is important to 
factor the structural, biological, and degradation properties into the matrix. 
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Chapter 3: 
Polymers and Polymer Composites 
3.1 Polymers for Tissue Engineering 
There are two main classes of polymers commonly used to create degradable 
porous matrices for tissue engineering applications, natural polymers and synthetic 
polymers.  Natural polymers used for tissue regeneration typically have superior 
biological properties but lack mechanical strength160, and synthetic polymers used for 
tissue regeneration typically have high mechanical properties but lack biological 
activity22.   
3.1.1. Natural Polymers  
Natural polymers tested as tissue scaffolds are derived from a variety of sources 
including fish scales, rat tails, and crab shells.  Unlike synthetic polymers, natural 
polymers have superior biological properties.  Scaffolds generated from natural polymers 
such as alginate 80, 161, 162, chitosan 77, 163-168, collagen21, glycosamioglycans (GAGs) and 
elastin 169-172, gelatin 5, 173, 174, and fibrin 175-177 have also been used as scaffolding 
materials 178-180.  A commonly used system is collagen/ GAGs 181, 182; collagen/ GAG 
based skin equivalents are already in clinical use 170, 171 and under investigation for other 
applications such as heart valves, vascular grafts 133, 183-187 and vascular networks 188.  
However, weak mechanical strength and inadequate tailorability in altering mechanical 
and degradation properties limit their usage.  Porous scaffolds formed of natural 
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polymers have a modulus of only 2 kPa, compared to 3 MPa for naturalurally occuring 
matrices such as SIS.3 
Chitosan is a polysaccharide derived from N-deacetylation of chitin, a polymer 
present in the outer shells of crustaceans77. Chitosan is composed of β (1-4) linked 2-
acetamido-2-deoxy-D-glucose and 2-amino-2-deoxy-D-glucose units.  It is a semi-
crystalline polymer, and the crystallinity is dependent on the degree of deacetylation.  
Chitosan is structurally analogous to GAGs, extra cellular matrix (ECM) elements 
present in the human body.  Since GAGs have specific interactions with growth 
factors/proteins, chitosan may share similar activity.  Chitosan is insoluble in water or 
organic solvents but soluble in aqueous acids (pH< 6.3).  Due to the protonation of the 
free amine groups on the chain backbone, chitosan exhibits a high charge density in 
solution.  This cationic nature and high charge density allow favorable interactions with 
negatively charged cells as well as antibacterial activity.  Chitosan has been widely 
investigated in wound dressing  and drug delivery systems 4.  The biocompatibility and 
biodegradability of chitosan makes it a promising material for tissue engineering189.  
Chitosan has shown biological activity towards diverse cell types including stem cells5, 
190
, chondrocytes168, 190, osteoblasts168, hepatocytes191, 192, and Schwann cells 193, 194.  In 
addition, chitosan has minimal immune reaction and its stimulatory effect can induce 
local cell proliferation5.  Chitosan can be degraded by lysozyme, a naturally occurring 
enzyme in vivo77.  The biodegradation time is determined by the amount of residual 
acetyl content, an easily controlled variable.  Due to the active amino groups, chemical 
modification of chitosan can produce materials with a variety of physical and mechanical 
properties.  Polysaccharide scaffolds were synthesized by crosslinking arabinogalactan, 
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dextran and amylose with chitosan to create a more cell compatible environment 195.  
Chitosan is also blended with collagen, alginate, GAG, and synthetic polymers (i.e. 
PLGA, PCL) to fabricate suitable scaffolds 196.  The pH dependent solubility, the easy 
processability under mild conditions, the modification reactivity, the biodegradability, 
and biocompatibility make chitosan an excellent candidate for use as porous scaffolds in 
tissue engineering. 
Hyaluronic acid (HA), a large linear GAG, is composed of repeating disaccharide 
of D-N-acetylglucos-amine-β-D-Glucuronic acid 197.  It is negatively charged, acts as a 
polyelectrolyte in solution, and acts as a lubricant 198.  Although HA is involved in 
mediating cell adhesion as an ECM component, its degradation rate is difficult to control 
199
. 
Collagens are a family of structural proteins reinforcing a variety of animal tissues 
including skin, bone, and tendon.  Collagen contains cellular-binding domains and has 
been extensively used in vascular tissue engineering.  Collagen has a triple helical 
structure of three polypeptide chains glycine, proline and hydroxyproline. Based on the 
amino acid sequences, collagen is of different types (over 28 different types have been 
identified) 200.  Type I collagen is a major component of most connective tissues, is 
present in the arterial wall 201 and small intestinal submucosa (SIS) 31, and is degraded by 
several matrix metalloprotenases (MMPs) 202.  It is tough and inextensible, with great 
tensile strength and controls cell shape and differentiation.   Type II collagen is the 
primary component of hyaline articular cartilage203 and is used as a marker for 
chondrocyte differentiation204. 
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Gelatin, a partially denatured derivative of collagen, has also been used to generate 
scaffolds5.  Gelatin is widely found in nature, and can be extracted from collagen found 
in fish, bovine bone, and porcine skin.  Gelatin blended with chitosan has been used in 
artificial skin and cartilage applications due to the ability to form a polyelectrolyte 
complex 172, 205.  Gelatin is a thermally denatured form of collagen and is isolated from 
animal skin and bones. Gelatin is primarily used as a gelling agent as it forms 
thermoelastic gels upon cooling to below 35°C, which dissolve at low temperature.  
Gelatin contains Arginine-Glycine-Aspartic acid (RGD)-like amino acid sequence that 
promotes cell adhesion and migration.  The physicochemical properties of gelatin can be 
suitably modulated due to the existence of both carboxylic acid and amine functional 
groups206.  Both the mechanical and degradation properties of gelatin can be modified by 
crosslinking.  Gelatin can be crosslinked using another molecule to connect the gelatin 
functional groups, for example gluteraldehyde 207, 208.  The gelatin functional groups can 
also be directly linked to each other without adding another molecule to the chemical 
structure (zero length crosslinking) using carbodiimides 209.   
Fibrin has been used for cartilage repair 210.  Upon injury, fibrinogen self-assembles 
to become 3D fibrin hydrogel 199.  Fibrin can bind to different integrin receptors to 
regulate cytokine gene expression as well as regulate inflammation.  Since fibrinogen can 
be obtained from the patient’s own blood, use of fibrin minimizes immunogenic 
concerns.  Another advantage of fibrin is that it can be degraded by cell-associated 
enzymatic system.  Despite these advantages, fibrin scaffolds failed to keep their shape 
integrity.  Fibrin gels showed significant reduction in size after in vitro incubation and 
weak compression modulus 211, suggesting a need for further modifications.   
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3.1.2. Synthetic Polyesters  
Synthetic polyesters such as poly (lactic acid) (PLA), poly (glycolic acid) (PGA), 
their copolymers (PLGA, PLLA, etc) 6-12, 23, 62, 107, and poly (caprolactone) (PCL) 212, 213 
have generated immense interest as tissue engineering materials due to their strong FDA 
approval history and numerous investigations in a variety of biological applications for 
more than three decades 13.  These polymers degrade by hydrolysis, and their degradation 
rates and mechanical properties can be altered via co- and graft-polymerization 
techniques 192, 214, 215, and by processing conditions 216-219.  Synthetic Polymers have been 
extensively reviewed in the literature 22, 201, 220 
PGA is a rigid thermoplastic material with high crystallinity and is hydrophilic 199.  
PLA is more hydrophobic than PGA due to an extra methyl group in the lactide molecule.  
Because lactic acid is a chiral molecule, PLA has D-PLA, L-PLA, and racemic 
stereoisomeric forms.  Of the two isomers L-PLA is more frequently used in tissue 
engineering because it possesses high mechanical strength 201.  Poly (lactic-co-glycolic 
acid) (PLGA) is the copolymer of glycolic acid and lactic acid.  Various ratios (75 
PLA:25 PGA, 50:50, etc) of PLGA have been investigated.  Amorphous 50:50 PLGA 
(50% lactic acid, 50% glycolic acid) is preferred for various tissue engineering 
applications because it degrades faster than other co-polymer ratios, which are semi-
crystalline.  The degradation of PLGA is via random hydrolysis of the ester bonds.  In 
addition, the degradation rate can be modified by changing the copolymer ratio and 
molecular weight (lower molecular weights degrade faster) 22.   
Poly (caprolactone) (PCL) is a non-toxic, biocompatible aliphatic polyester 22 with 
a melting point of only 60ºC110.  PCL can be readily dissolved in acetic acid and 
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structures can be formed by several techniques221.  PCL has a degradation time dependent 
on its molecular weight222.  High molecular weight degradation times are of the order of 
two to three years make which it unsuitable for short term implants.  PCL is a 
chemosynthetic polymer poly (ε-caprolactone) (PCL), due to its high degradation rate 
relative to chitosan, better tensile properties, low melting point (60°C) which allows easy 
processing, and lack of charge contribution to the system110. PCL films formed after 
dissolving in chloroform have shown elongation up to 1000% before break 223.  PCL has 
limited bioregulatory activity and hydrophobic, neutral charge contribution, and 
susceptible to bacteria-mediated degradation.  PCL dissolves in chloroform and other 
organic solvents but not in water but chitosan dissolves in acidic water and not in many 
organic solvents.  Thus, solvent annealing of the formed blends is also possible apart 
from thermal annealing. 
Poly (ethylene glycol) (PEG) is a biocompatible polymer with a high solubility in 
water.  However, PEG is not hydrolytically degraded, unlike other synthetic polymers 
commonly used in tissue engineering.  PEG chains under 50 kDa can be completely 
eliminated from the body224.  Therefore PEG is typically used in combination with 
degradable crosslinks such as PLA225.  The highly soluble nature of PEG makes it an 
ideal material for hydrogels224 or for increasing the solubility of other molecules.  
Because it does not degrade hydrolytically it has been used as a barrier material to 
encapsulate and protect the cells destroyed in a diabetic patient (Islets of Langerhans)226.   
Synthetic polymers show poor regulation of cellular activity 227.  Furthermore, their 
degradation products are relatively strong acids and cause inflammation 228.  The 
scaffolds also show structural instability due to massive swelling during degradation 218.  
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Apart from adhesive interactions, a substrate has to mediate a variety of signals such as 
growth factor activity to regulate the biological response of diverse cell types.  Despite 
significant efforts to improve these limitations via co-polymerization 229 and grafting 
arginine-glycine-aspartate (RGD) peptides (necessary for cellular attachment) 230, 
recreating all the biological responses may not be possible without incorporating 
controlled delivery systems into the porous structure. 
3.2 Combining Natural and Synthetic Polymers 
Currently there is not a synthetic material that provides all the essential properties 
present in natural matrices, such as SIS (Table 1).  While natural polymers have the 
benefits of facilitating cell adhesion and repopulation by providing critical signals, they 
lack tailorability of mechanical properties.  In contrast, synthetic materials possess 
advantages of easy control of microstructure, strength and degradation rate, but they lack 
the attachment domains and cellular signals that direct cell growth, proliferation, and 
differentiation 201.  Therefore, one current area of research in combinations of natural and 
synthetic polymers in order to exploit the benefits of each polymer while minimizing the 
weaknesses.  There are two approaches generating synthetic matrices for tissue 
engineering materials. 
a) Synthesize novel materials with different functional groups 
b) Combine the existing materials in different modes.  
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Table 1. Summary of polymer properties 
 Natural 
Matrices 
(SIS)3 
Natural 
Polymers 
(Chitosan)77 
Synthetic 
Polymers 
(PLGA)16 
Mechanical 
Strength 
3 MPa 2 – 6 kPa 1 – 9 MPa 
Degradation 
Time 
4 weeks 6 – 12 
months 
4 weeks 
Cellular 
Support 
Yes Yes No 
 
The focus of this work focuses on combining natural and synthetic polymers 
using SIS as a design basis.  Several methods are being examined including coating, 
copolymerization, blending, and forming composite structures.  
 
3.2.1. Multiphase Polymer Architecture 
Several different 3D porous architectures are possible when combining dissimilar 
polymers.   A combined polymer scaffold’s properties are influenced by the 3D 
partitioning of the polymer phases present in the matrix.  For example, one reason that 
freeze dried PLGA-chitosan emulsions have less mechanical strength then scaffolds 
formed from pure chitosan is that the two polymer phases formed within the emulsified 
scaffolds do not support each other mechanically as well as the single phase in the 
chitosan scaffold231.  The polymer phases within a 3D porous structure may be distributed 
in a variety of ways, and as either continuous or dispersed phases. 
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3.2.2. Coatings 
The simplest method for combining separate polymers involves utilizing them to 
coat other materials.  PGA matrices have been coated with PLGA in order to stabilize and 
increase their mechanical strength232.  Polyurethane has been coated with collagen in 
order to improve its biological functionality233.  Additionally, chitosan has been used as a 
bioactive coating for a variety of materials from PLA234 to stainless steel235.  Chitosan 
coatings have even been used on food products because of chitosan’s antibacterial 
properties236. 
3.2.3. Copolymerization 
Several techniques used to improve the performance of tissue engineering devices 
revolve around using copolymerization.  A multitude of copolymerization strategies have 
been used in tissue engineering applications.  There are two basic strategies for 
copolymerization, modifying the surface of a polymer structure or forming multiple block 
monomers and then polymerizing the whole matrix.  For surface modification, the 
underlying polymer fibers are formed and then a surface layer of the new polymer is 
created on top of the base polymer material.  For example chitosan and collagen have 
been grafted to PET fibers, and the modified fibers improved fibroblast proliferation237.  
Additionally, biologically active compounds (proteins, peptides, DNA, etc)can be grafted 
onto polymers to improve their bioactivity.  A variety of peptides containing cellular 
binding domains (such as RGD) have been grafted onto polymer structures 238.   
For block copolymerization, the copolymer is formed in homogeneous solution 
and then formed into the final scaffold using standard processing techniques such as film 
formation239, photopolymerization240, self assembly into nanoparticles241, or 
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electrospinning242.  These blocks can be as simple as grafting chitosan to PCL241, and 
grafting chitosan to sugars and GAGs (such as lactose and heparin) has been shown to 
increase extracellular matrix production in in vitro cartilage tissue engineering 239.  The 
individual copolymer blocks can also be synthesized in complicated nested blocks.  For 
example Bramfeldt et al synthesized P(CL-co-DLLA)-PEG-P(CL-co-DLLA) block 
copolymers for tissue engineering applications.  This polymer contains a copolymer of 
PCL and PLA with a PEG block linking the copolymer sections 243. 
Additionally, copolymerization has been used to synthesize a variety of 
temperature sensitive polymers or use as drug delivery vehicles.  Several examples use 
chitosan as a backbone and then chemically attach another polymer to provide 
temperature sensitivity.  Both (N,N-dimethylamino)ethyl methacrylate244 and PEG245 
have been grafted onto the chitosan backbone in order to create temperature sensitive 
polymers for drug release.  Additionally, comblike structures have been created using 
chitosan as a backbone and temperature sensitive polymers, such as poly(N-
isopropylacrylamide), as the extensions to fabricate temperature sensitive hydrogels 246.   
3.2.4. Blending 
Another common method of combining natural and synthetic polymers is to 
physically blend them without forming chemical bonds.  A key aspect in blending is 
finding a common solvent for the polymer system.  The polymers are dissolved and then 
processed into porous structure as a homogeneous phase.  One common system for 
blending is chitosan and chitin with PCL 247.  Chitosan and PCL have been blended using 
acetic acid and water as a common solvent followed by freeze drying, and then analyzed 
for increased mechanical properties, adhesion and proliferation of fibroblasts, and anti-
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bacterial activity111, 248. PCL and chitosan have also been blended and formed into porous 
matrices using phase separation249.  Chitosan and PGA have been blended using acetic 
acid and dimethyl sulfoxide (DMSO) as solvents, freezing the blend, and then 
neutralizing the frozed scaffold with NaOH to precipitate out the 3D porous structure 250.  
PLGA and chitosan have been blended using a novel solvent and wet spun into fibrous 
mats.  These matrices were tested for improved properties including mechanical strength, 
water uptake, degradation, chondrocyte viability, and GAG production 251.  Melt blending 
is another technique that can be used to combine chitosan with a number of synthetic 
polyesters including PLGA.  However, the melt blending process forms nonporous 
blocks which must be further processed into porous structures suitable for tissue 
engineering 252.  Additionally, homogeneous blends of chitosan and PLGA can also be 
fabricated into 3D porous structures by using solvent extraction to create a 
homogeneously blended gel and then freeze dried to create a porous structure 253.   
When a common solvent for cannot be found an emulsification system may be 
used.  The emulsifier effectively binds the heterogeneous phases together as a collection 
of microscopic droplets which do not revert back into two separate phases.  For example 
one method for combining PLGA and chitosan uses an emulsification system because no 
simple solvent will dissolve both chitosan and PLGA 231.  Freeze dried scaffolds have 
been synthesized from the emulsions of the chitosan and PLGA.  The emulsified 
scaffolds showed minimal smooth muscle cell spreading and proliferation, but their major 
problem was lack of physical strength 231.  Recently, it was shown that the observed 
difference in these emulsions is due to structural weakness in the matrix and minimal 
electrostatic cell adhesion to chitosan5.  The lack of mechanical strength is a result of 
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dispersed polymer phases in the material.  The freeze dried product is formed from two 
separate polymer phases because the emulsion is a two phase mixture.  The PLGA phase 
cannot provide structural reinforcement because it lacks a continuous phase capable of 
carrying the mechanical load 231. 
3.2.5. Composites 
Several strategies have been used to combine natural and synthetic polymers 
including blending, emulsifying, and coating.  However, these methods suffer from an 
inability to separately optimize the physical and biological properties of the scaffold.  An 
alternative to uniformly blending natural and synthetic polymers is to form composite 
matrices.  Several composite systems have been developed.  Some examples of how 
multiple polymers can be combined using a composite structure: filling the pores in a 3D 
matrix, fabricating interlocked layered structures, or embedding nanoparticles within the 
porous matrix. 
One method for creating multiplier composites is to fill the pore spaces in a 3D 
matrix with another material.  For example collagen microsponges have been fabricated 
within a porous PLGA backbone 254.  Additionally a 3D composite has been by filling the 
pore spaces with agar or gelatin 255.   
Another method uses composites based on a multiple layer structure.  For 
example a composite structure of consisting of chitosan and silicon layers has been used 
as a dermal equilivant for wound healing and burn injuries 256.  This work explored the 
generation of a composite matrix to mimic the mechanical properties of distal SIS257.  A 
three layered composite structure is employed in order to independently control the 
mechanical and biological properties of the scaffold.  The composite matrix consists of 
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two 3-D chitosan layers reinforced with a PLGA membrane.  The outer layers of porous 
chitosan provide a 3D natural polymer structure scaffolding for multi-layered cell growth, 
and the inner PLGA layer provides mechanical strength through a continuous synthetic 
polymer phase16.   
3.3. Materials and Methods. 
3.3.1. Sources for Material. 
Chitosan with >310 kDa MW and 85% degree of deacetylation, urea, Dulbecco’s 
modified Eagle medium (DMEM), lysozyme, glucose, sodium bicarbonate, Medium 199 
(M199), HEPES, bacteriologic peptone, sodium chloride, resazurin, and tetrahydrofuran 
(THF) were obtained from Sigma Aldrich Chemical Co (St. Louis, MO).  Nineteen kilo-
Dalton 50:50 PLGA was obtained from Alkermes Inc., (Cambridge, MA) while 75kD 
and 160kD 50:50 PLGA were purchased from Birmingham Polymers (Birmingham, AL).  
A urea assay kit was obtained from Diagnostic Chemicals Limited (Oxford, CT).  Alexa 
Fluor 488 phalloidin was from Molecular Probes (Eugene, OR).  Mouse embryonic 
fibroblasts (referred to as STO cell line) were purchased from American Tissue Culture 
Collection (Walkersville, MD).  L-glutamine, penicillin-streptomycin, amphotericin, 
trypsin/EDTA, MEM vitamins, MEM Amino Acids, propidium iodide, and Fetal Bovine 
Serum (FBS) were purchased from Invitrogen Corp. (Carlsbad, CA).  MMP2/MMP9 
fluorogenic peptide (DNP-Pro-Leu-Gly-Met-Trp-Ser-Srg-OH) was purchased from 
CalBiotech (Spring Valley, CA).  Bicinchoninic acid (BCA) protein assay kit was 
purchased from Pierce Protein Research Products (Rockford, IL). 
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3.3.2. Composite Layered Scaffold Fabrication.   
The composite scaffold was fabricated using a custom Teflon/silicon well system 
developed in house.  Procedure used in generating the composite structure is shown in 
Figure 8.  First, a 1/32” thick Teflon sheet (United States Plastic Corp, Lima, OH) was 
affixed to a flat aluminum plate using silicon glue.  Teflon was used to provide a nonstick 
surface for the PLGA and the aluminum provided physical support to keep the Teflon 
flat.  A 6 cm × 8 cm well was formed on the Teflon sheet using silicon glue (Silicone II, 
GE Sealants and Adhesives, Huntsville, NC) (Figure 9A).  Five milliliters of 4% (wt/v) 
PLGA solution, prepared in chloroform, was poured into the well and air dried in a 
chemical hood overnight.  The silicon was trimmed away and the PLGA film was 
perforated with a custom punching apparatus, developed in house.  The puncher consisted 
of a Teflon grid marked in a 1 cm × 1 cm pattern.  The PLGA film was placed on the grid 
and perforations were made using stainless steel nails (Figure 9B).  At this point 
perforation size was analyzed by light microscopy, using the technique described in the 
thickness characterization section below.  The perforated film was placed on a new 
Teflon sheet and a well was formed using silicon glue.  The membrane was layered with 
10 mL of 0.5% (wt/v) chitosan solution with 0.7% (v/v) acetic acid, frozen at -80ºC, and 
lyophilized overnight.  The silicon was removed, then the sample was flipped, and a new 
silicon well was formed.  The well was filled with ten milliliter of chitosan solution, 
frozen at -80ºC and lyophilized overnight.  The silicon was removed and the samples 
were stored in a vacuum desiccator.  Before any subsequent use, the composite 
membranes were neutralized in ethanol and washed with phosphate buffered saline 
(PBS).  At each step of the process, samples were analyzed with a scanning electron 
 45 
microscope (SEM) to ensure the 3D structural design elements were incorporated into the 
final scaffold. SEM images were colorized using Paint Shop Pro (Corel Corporation, 
Minneapolis, MN). 
 
Figure 8. Schematic showing the steps involved in forming the composite scaffold 
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Step 1.  Dissolve PLGA in chloroform 
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Step 4. Form chitosan matrix on one side 
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N
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Figure 9. Construction of the Composite Scaffold 
Panel A.  Silicon glue is used to create a well for solvent casting.  Panel B.  The 
custom punching apparatus used to create perforations in the PLGA films 
3.3.3. Thickness Characterization. 
PLGA films, 75kDa and 160 kDa MW, were cast in Teflon/silicon wells as 
described above.  However, PLGA films with 19 kDa MW were formed in Teflon petri 
dishes because they leaked out of the silicon wells.  The thickness of the polymer 
membranes was measured optically because the polymers are to soft to be reliably 
measured with a micrometer caliper.  All membranes were cut into small (~2 mm wide) 
strips, and oriented orthogonal to the plane of view of an inverted microscope so that the 
cross section could be viewed.  Digital micrographs of the cross section were recorded 
using a CCD camera.  The cross sections were measured using Sigma Scan Pro software 
(Systat Software, Inc., Point Richmond, CA) which was calibrated using an image of a 
hemacytometer.  For each sample, thicknesses were measured at forty or more locations 
and average values were used in all calculations.  
 
A. B. 
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3.3.4. Uniaxial Tensile Testing. 
Tensile properties of the matrices were measured by the method described 
previously3, 110.  In brief, 6 cm × 1 cm strips were cut from each sample and analyzed 
using an INSTRON 5842 (INSTRON Inc., Canton, MA) with a constant crosshead speed 
of 10 mm/min.  Tests were performed at room temperature under hydrated conditions 
using a custom designed chamber.   
3.3.5. Microarchitecture Analysis.  
To evaluate the microarchitecture of the matrices, samples were analyzed using a 
scanning electron microscope (JOEL scanning microscope, Peabody, MA).  For this 
purpose, samples were dehydrated using a series of increasing concentrations of ethanol 
followed by a brief vacuum drying.  Samples were sputter coated with gold at 40 mA 
prior to observing under SEM.   
3.3.6. Permeability Measurement. 
Permeability of urea was measured using the method described by Raghavan et 
al3.  The urea assay was used because urea is a small molecule that is biologically 
important.  This method utilizes a custom designed chamber shown in Figure 10.  In 
brief, one side of the permeability chamber (chamber 1) was filled with 4 mL of 550 mM 
urea in PBS.  The 550 mM urea concentration is the average concentration found in a 
human bladder.  A 2.5 cm × 2.5 cm section of the composite was placed on top of the 
solution, and the chamber was assembled.  The other side of the sample (chamber 2) was 
filled with 4mL PBS using a syringe through the sample port.  The chamber was 
maintained at 37°C.  At regular intervals, nearly 100 µL samples were taken for 8 hours.  
 48 
The concentration of urea was determined using a commercially available kit (Diagnostic 
Chemicals Limited, Oxford, CT) following the vendor’s protocols.  In brief, 20 µL of 
sample was added to 2 mL of urease solution and the rate of change in absorption, at 340 
nm, was measured for 90 s.  The concentration of urea was determined using a calibration 
curve prepared between 0 to 275 mM urea. 
 
 
Figure 10. Diagram of the Chamber used in Permeability Experiments 
3.3.7. Degradation Characterization. 
To understand the influence of composite formation, degradation studies were 
performed using the method described by Moshfeghian et al with minor modification231.  
In brief, samples were cut into 1 cm × 1 cm strips, neutralized and sterilized with ethanol, 
rinsed twice with  sterile PBS, placed into sterile individual 20mL scintillation vials, and 
incubated at 37ºC in 10 mL sterile PBS containing 10 mg/L lysozyme.  The lysozyme 
Chamber 2 
(C2) 
Contains 
PBS 
Chamber 1 
(C1) 
Contains Urea  
Solution 
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containing PBS solution was changed every 7 days and the pH of the spent PBS was 
measured.  Four matrices per group were sacrificed at 1, 7, 15 ,23 ,28, 35, 42, 49, and 56 
days and weighed.  For weight determination, samples were dehydrated using an 
increasing concentration of ethanol (0, 25, 50, 80, and 100%) and briefly vacuum dried.  
Some of the samples were then examined by SEM to evaluate changes in the 
microarchitecture as described before. 
The molecular weight of PLGA present in the samples from 0, 23, 35, and 49 
days was measured using gel permeation chromatography (GPC), Agilent 1100 series 
(Santa Clara, CA), and associated software Chemstation.  In brief, samples from 
degradation study were dissolved in tetrahydrofuran (THF) at a concentration of 
5mg/mL.  Only PLGA dissolved in THF and not chitosan.  This was confirmed by 
dissolving pure chitosan and pure PLGA in THF and analyzing in GPC.   The samples 
were filtered through a 0.2µm filter to remove any particulates.  They were injected into 
the GPC column (Polymer Laboratories, Amherst, MA), and then eluted at 30 bar and 
40ºC using a 1 mL/min flowrate.  Additionally the column was calibrated using two 
polystyrene standards, one with 600 kDa, 100 kDa, and 9 kDa molecular weights and  
another with 390 kDa, 17 kDa, and 0.8 kDa molecular weights.  
3.3.8. Cell Culture. 
Mouse embryonic fibroblasts (MEFs), from American Tissue Culture Collection 
(Walkersville, MD), were maintained in Dulbecco's modified Eagle's medium (DMEM) 
supplemented with 4 mM glutamine, 4.5 g/L glucose, 1.5 g/L sodium bicarbonate, 100 
U/mL penicillin-streptomycin, 2.5 mg/mL amphotericin B, and 10% fetal bovine serum 
(FBS).  Cells were maintained at 37ºC, in a 5% CO2/95% air and fed with fresh medium 
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every 48 h. Cells were dissociated with 0.01% trypsin / 10 mM EDTA, centrifuged, and 
resuspended in medium prior to cell seeding.  
Canine bladder smooth muscle cells (SMC), a kind gift from Dr. Bradley Kropp, 
Department of Urology, University of Oklahoma Health Science Center (Oklahoma City, 
OK) were maintained in Medium 199 (M199) supplemented with 1g/L glucose, 2.2 g/L 
sodium bicarbonate, 3.56 g/L Hepes, 0.5g/L bacteriologic peptone, 100 U/mL penicillin-
streptomycin, 2.5 mg/mL amphotericin B, 1% MEM vitamins, 1% MEM amino acids, 
and 10% FBS.  Cells were maintained at 37ºC, in a 5% CO2/95% air and fed with fresh 
medium every 48 h. Cells were dissociated with 0.01% trypsin / 10 mM EDTA, 
centrifuged, and resuspended in medium prior to cell seeding. 
3.3.9. Cell Colonization. 
Cell colonization and activity were evaluated on tissue culture plastic (TCP), 2-D 
PLGA films, and 3-D composite scaffolds.  For both fibroblast and SMC experiments the 
samples prepared as described above, were cut into circular pieces, sterilized with 
ethanol, rinsed twice with PBS, and inserted into 24-well cell culture plates.  Cell growth 
media was added to the wells prior to seeding 30,000 cells per sample.  After three days, 
cell spreading and attachment was examined using SEM and actin staining 258.  In brief, 
cell-containing scaffolds were fixed in 3.7% formaldehyde for 15 min at room 
temperature.  Cells were washed with PBS and permeabilized with -20°C ethanol for 30 
min at -4°C, and then incubated with Alexa Fluor 488 phalloidin for 1 h at room 
temperature in the dark.  SMCs were also stained for DNA by incubating with 1mg/mL 
propidium iodide for 30 minutes and washing four to five times.  Cell morphologies were 
examined using an inverted fluorescence microscope (Nikon TE2000, Melville, NY).  
 51 
Some matrices were dehydrated using a series of increasing concentration of ethanol and 
analyzed via SEM, similar to microarchitecture analysis described above. 
3.3.10. Cellular Activity. 
Fibroblast cellular activity was examined using a functional assay for matrix 
metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) 259.  In brief, 100µL 
of cell supernatant was incubated with 100µl of a 100 µM solution of fluorogeneic 
peptide specific for MMP-2/MMP-9 (DNP-Pro-Leu-Gly-Met-Trp-Ser-Srg-OH).  After 
20min at room temperature fluorescence measurements were taken at 320 nm excitation 
and 405 nm emission.  The amount of fluorescence was then normalized using the total 
protein content of the samples (measured using a commercially available BCA total 
protein assay).  Cell viability was measured using the method described in Larson et al 
260
.  In brief cells were incubated in 0.1% resazurin solution for three hours then the 
absorbance of the supernatant was measured at 540nm.  Growth medium incubated 
without any cells served as control. 
3.3.11. Statistical Analysis.  
All experiments were repeated three or more times with triplicate samples.  
Statistical analysis was preformed using analysis of variance (ANOVA) and difference 
among the means was considered significant when p<0.05.  
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3.4. Results. 
3.4.1. Composite Scaffold Physical Properties. 
A major challenge in generating the composite scaffolds was attaching the 
hydrophobic PLGA layer to the hydrophilic chitosan layer.  Therefore a mechanically 
interlocked composite scaffold was formed in three layers.  The interlocking was created 
by perforating the PLGA layer and having the chitosan compartment run continuously 
through the perforations.  Using this concept, thin PLGA membranes (thickness of 50 (± 
16)µm) were generated and perforated using  stainless-steel nails.  The PLGA 
perforations were rectangular with sides between 300µm and 550µm long (Figure 11A).  
The perforation size was determined by the size of the nail used.  After the addition of 
one chitosan layer, the porous chitosan structure was visible through a perforation in the 
PLGA layer (Figure 11B).  This shows that there was good contact between the layers.  
After the addition of second layer of porous chitosan, micrographs showed that the 
chitosan forms a continuous layer through the perforations (Figure 11C).  The dry 
thickness of these composite scaffolds was roughly 2mm and the PLGA membrane 
contributed only fifty micrometers.  Hence, large thickness was a result of the chitosan 3-
D structures.  No separation of layers occurred when the samples were neutralized with 
ethanol and hydrated in PBS, suggesting that the composite was firmly anchored at the 
perforations.  
  
 
 
Figure 11. Composite Scaffold Structure during Fabrication.   
Scanning electron micrograph of (A) a perforation made in the PLGA film,  (B) a perforation in the 2 layer Chitosan-PLGA 
structure, and (C) the composite structure showing the continuity of the porous chitosan layer through a perforation in the 
PLGA 
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3.4.2. Tensile Properties.   
First, influence of MW of PLGA on the tensile properties was characterized in 
hydrated conditions (Figure 12A).  The Teflon-silicon well system was developed in-
house because the standard Teflon Petri dishes have an uneven surface that results in a 
film with variable thickness.  PLGA films with 75 and 160 kDa MW s were formed in 
custom silicon wells, however 19 kDa PLGA solution leaked out of the silicon wells and 
had to be cast in Teflon Petri dishes.  As expected, tensile strength increased with 
increasing MW.  These results showed that 160 kDa membranes to possess tensile 
strength values greater than SIS.  Hence, 160 kDa PLGA membranes were used in all 
subsequent analyses.   
To understand the effect of various fabrication steps on the mechanical properties 
of PLGA, stress calculations were based only on the thickness of the PLGA films (~50 
µm) for all materials.  The PLGA membranes retained their mechanical strength within 
the composite scaffold, and remained mechanically unaltered under tensile loading.  
Repeated freeze-drying did not affect the tensile properties of PLGA (Figure 12B).  The 
stress strain curves were non-linear, and the composite structure stretched more than SIS 
before failure.  The composite structure had a break stress between 3.5 and 5 MPa which 
is comparable to the tensile stress of distal SIS (3MPa).  The modulus of elasticity in the 
initial linear range (<15% strain) for the composite structure was 45 ± 11 KPa, and the 
modulus of elasticity for 160 kDa PLGA films was 250 ± 41 kPa.  The chitosan layers 
broke in a tiled pattern (on both sides of the membrane), and the chitosan tiles remained 
attached to the PLGA at the site of the perforations (Figure 12B, Inset).  The stress strain 
curve for the composite also showed that point where the chitosan layer failed.  The small 
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decrease caused by the chitosan failure (Figure 12B) shows that the majority of the 
composite scaffold’s mechanical strength came from the PLGA layer.   
 
 
Figure 12. Stress Strain Characteristics.   
A) Effect of MW of PLGA.  B) Behavior of the Composite.  Inset is a schematic 
showing composite with a single perforation and chitosan break pattern. 
 
3.4.3. Permeability to Urea. 
Next, the effect of perforations on the permeability of urea was examined to 
reaffirm that the perforations were filled with chitosan.  If the scaffold is mechanically 
interlocked through the perforations, then the interlocks should create a barrier to 
diffusion.  This barrier will lower prevent transport of urea and lower the permeability 
drastically.  First, the permeability of unperforated PLGA membranes was tested for 48 
hr, showing negligible presence of urea in the opposite compartment.  Next the 
composite’s permeability was tested.  These results showed that the composite scaffold 
was much less permeable to urea than SIS (Figure 13).  After eight hours, the final 
concentration of urea that had diffused through the composite was 80 mM while urea 
diffusing SIS reached that concentration less than 30 minutes.  Additionally, the 80 mM 
final concentration was only 30% of the expected equilibrium concentration of 275 mM, 
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and after 8 hours the concentration of urea in chamber 1 (the initial loading side) was 
significantly higher.  The lack of permeability shows that the chitosan layer was blocking 
the perforations, preventing urea transport.   
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Figure 13. Diffusion of Urea across Composite Membrane. 
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3.4.4. Scaffold Degradation Characteristics. 
In order to understand the utility of composite scaffolds, it was necessary to 
evaluate their degradation characteristics.  For this purpose, samples were incubated in 
PBS containing 10mg/mL lysozyme.  These results showed no significant changes in the 
width and length of the scaffolds.  However, the scaffolds gradually lost their structural 
integrity and could no longer be handled with forceps at week 8.  Of the 5 samples 
stopped at week eight, only two were successfully removed from the vials and weighed.  
Further, no significant changes were observed in the overall superstructure of the 
scaffolds over 4 weeks (Figure 14).  Both the layered and porous elements of the scaffold 
were maintained over the full eight weeks, showing that the layers remained 
mechanically interlocked as the sample degraded.  However, the chitosan layer developed 
a fluffy texture and the PLGA turned white as the degradation progressed.  The mass loss 
data showed a slow decline to 80% of the starting mass in week 5 then a jump to 50% of 
the starting mass by week 8 (Figure 15A).   
 
Figure 14. Composite Membranes Retain their 3D Structure during Degradation.  
(A) Cross Sectional View of the Composite Membrane after 21 days in PBS, and (B) 
Top View of the Composite Membrane after 21 days in PBS. 
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To better understand scaffold degradation characteristics, the MW and Mn of 
PLGA were measured using GPC.  These results showed a continuous linear decrease in 
both MW and Mn.  The MW reduced by 50% after 3 weeks and by 80% after 7 weeks 
(Figure 15B).  The slope of MW/Mn (polydispersity index) of the samples remained 
constant at 1.64 for all 7 weeks.  The large drop in scaffold weight from week 5 – week 7 
could be attributed to the decreasing MW of PLGA.  PLGA molecules could not 
disentangle themselves from the bulk polymer until their MW was reduced.  As shown in 
Figure 12A, a drop in MW of PLGA to 19 kDa caused a significant drop in mechanical 
strength.  The loss of mechanical strength leads directly to the loss of structural stability 
seen in Figure 15A.  This further emphasizes that the composite’s mechanical properties 
are directly controlled by the PLGA layer. 
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Figure 15. Degradation Characteristics of the Composite. 
(A) Weight Loss.  (B) Changes in PLGA molecular weight (MW) and molecular 
number (Mn). 
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3.4.5. Support for Cellular Activity. 
Cell morphologies were evaluated to understand whether composite matrices 
support cell colonization.  Cytoskeletal organization of MEFs was probed via actin 
staining. These results showed that PLGA films alone altered the shape of the cells 
relative to tissue culture plastic surface and the typical spindle shape of fibroblasts was 
not observed.  However, on 3-D composite matrices, MEFs showed well spread spindle 
shape, similar to previous publications (Figure 16A - C)5, 14.  In addition, cellular 
attachment mimicked the pore morphologies of the scaffold showing that cell spreading 
and adhesion appeared to be guided by the porous structure.  MEFs showed peripheral 
distribution of actin filaments, similar to cells on tissue culture plastic surface.  Further 
analysis by SEM confirmed (Figure 16D-E) that cells on the PLGA films had reduced 
spreading.  On the contrary, the cells on all 3-D composite matrices exhibited their 
typical elongated shapes.  In addition, extensions resembling lamellapodia were also 
observed.  
  
A. B. C.
D. E.
250 µm 250 µm 250 µm
 
Figure 16. Composite Matrices Guide the Spreading, Adhesion, and Proliferation of MEFs.  
Fluorescence micrographs of actin stained cells on (A) Tissue culture plastic, (B) 2-D PLGA films, and (C) 3-D composite 
scaffolds.  Scanning electron micrographs of (A) 2-D PLGA films and (E) 3-D composite scaffolds.   Arrows indicate the 
position of cells. 
61
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Viability of MEFs was measured by monitoring the metabolic oxidation of 
resazurin.  The decrease in resazurin absorbance was similar for all samples, showing that 
the composite structure supported viable cells (Figure 17A).  To understand the 
functionality of fibroblasts, the amount of MMP-2/MMP-9 secreted into the growth 
medium was monitored using a fluorogeneic substrate specific for MMP-2/MMP-9.  
Figure 17B shows the MMP-2/MMP-9 activity in relative fluorescence units (RFU) per 
mg total protein.  The RFU/mg is similar for all samples, showing that the composite 
scaffold does not harm the activity of MEFs.  Additionally the decrease in activity seen in 
the TCP and PLGA samples by day 7 could be attributed to the contact inhibition of 
overconfluent cells and thus producing less MMP-2/MMP-9.  However, this decrease 
was not observed in the composite scaffold as the 3D porous structure offered a larger 
surface area for cell attachment and may not have reached confluency. 
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Figure 17. Composite matrices support fibroblast colonization and activity. 
(A) Viability shown in relative absorbance units (RAU).  (B) MMP2/MMP9 activity 
shown in relative fluorescence units (RFU) per mg of total protein in the medium. 
 
 
Additionally, the colonization of SMCs on the composite structure was analyzed 
by SEM (Figure 18A,B) and fluorescence microscopy (Figure 18C).  Results showed a 
large number of cells attached to the composite scaffold.  Additionally, the cell structures 
mimicked the pore morphology suggesting that the porous structure can be used to guide 
the ingrowth and spatial arrangement of cells.
  
 
Figure 18. Composite matrices guide the spreading and adhesion of SMCs.  
Scanning electron micrographs of smooth muscle cells on both (A) Chitosan and (B) Composite Scaffolds.  Arrows indicate the 
position of cells.  (C) Fluorescence micrograph of propidium iodide and actin stained composite scaffold.64
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3.5. Discussion. 
The formed composite contained a three layer sandwich structure with two porous 
chitosan layers surrounding a continuous PLGA layer.  The three layers were 
mechanically interlocked with the two chitosan layers forming anchor points through 
perforations in the PLGA.  Perforations were formed by puncturing the PLGA film in a 
1cm x 1 cm square pattern using stainless steel nails. Using this method the perforation 
size and layout could easily be controlled.  Additionally, the composite matrix proved to 
be less permeable to urea than SIS 3.  Even after 48 hours the composite did not show 
appreciable urea diffusion.  The lack of diffusion is a result of the transport barrier 
created by the mechanical interlocking, showing that the perforations were sealed by the 
chitosan layers.  The reduced permeability should help limit inflammation by preventing 
urea leakage into surrounding tissue.   
Three different MW of PLGA were tested mechanically.  Since 160 kDa PLGA 
membranes showed tensile strength values greater than SIS, they were used exclusively 
when fabricating the composite structure.  The composite showed tensile properties 
similar to SIS 3.    The stress strain curve exhibited non-linear behavior and the break 
stress of the composite was larger then SIS.  As expected, mechanical failure of the 
chitosan layers showed very little effect on the stress strain curve.  Therefore, the 
majority of the composite matrix’s tensile strength was provided by the PLGA 
membrane.   This provides an opportunity to alter the bioregulatory properties of the 
chitosan matrix without greatly affecting the mechanical properties of the composite.  
Nevertheless, further mechanical testing including cyclical tests or burst stresses should 
be performed to explore the utility of formed composite matrices in tissue engineering 
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applications.  The composite’s nonlinear stress-strain behavior also suggests the 
possibility of viscoelastic behavior.  Therefore, it would also be useful to model the 
viscoelastic behavior of the composite structure and compare it to SIS.  Additionally, the 
strain for both PLGA films and composite structure was higher than other literature 
sources.  Using 50:50 PLGA, others have reported up to 80% strain using acetone as the 
solvent261.  Previously, we have reported that the solvent affects the properties of the 
matrix.  For example, using PCL membranes cast after dissolving in chloroform had an 
extension up to 1000% whereas membranes cast in water after dissolving in acetic acid 
had only 30% strain110.  The variability of mechanical properties may be a result of the 
microstructural architecture of the material.   
Long term composite degradation studies showed significant overall weight loss 
over eight weeks (50%).  The weight loss was accompanied by a linear reduction in the 
MW of PLGA layer, reducing the MW by 80% over 7 weeks.  A linear drop in MW is 
expected because PLGA degrades hydrolytically.  The drop in MW correlates to a drop in 
mechanical strength and a loss of structural stability.  After 8 weeks the scaffolds cannot 
be handled.  This showed that the physical properties of the composite scaffold are 
primarily controlled by the PLGA layer. 
Previous research has shown that porous chitosan matrices show support for cell 
growth and attachment of various cell types including fibroblasts and SMCs 14, 231, 258.  
Using both MEFs and SMCs the composite matrices demonstrated cell spreading 
characteristics similar to chitosan matrices.  Additionally fibroblasts were found to be 
viable (capable of oxidizing resazurin) and functional (produced active MMP-2/MMP-9).  
This showed that the process of creating a composite scaffold does not hinder the 
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chitosan layers’ capacity for cell colonization or the potential for cell growth.  
Additionally, all the cell culture experiments were performed at a single seeding density 
and cells were seeded on only one side of the composite structure.  The low density of 
seeding could have resulted in the i) cells remaining distant from each other, ii) attached 
to bottom of the pores near the vicinity of the PLGA membrane, and iii) decreased mass 
transfer of nutrients/waste products due to non-porous PLGA membrane.  Previous 
research indicated that raising the seeding density shows a greater change in cell growth 
between the 2D and 3D chitosan material 14.  Cells may also have entered into the 
scaffold and attached to or been influenced by the PLGA layer. 
Based on the need to alter the biological activity, one could complex chitosan 
with other bioactive polymers such as gelatin5 or glycosaminoglycans258.  In order to 
better mimic the biological properties,  one could incorporate biodegradable 
nanoparticles to deliver essential growth factors262.  Cellular signals could be better 
controlled by adding a controlled release delivery mechanism to the composite scaffold.  
The multilayer design also shows the potential to grow multiple tissue layers 
simultaneously.  For example, smooth muscle cells may be seeded onto one side of the 
composite while urothelial cells are seeded on the other to regenerate multilayer bladder 
tissue.  Each side could be embedded with a different loaded enabling a heterogeneous 
release of signaling molecules.  Additionally, the central layer should provide a barrier 
between the two tissue compartments, preventing in-growth of one cell type into the other 
until both regenerated tissues have time to reorganize.  
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This method for fabricating composite scaffolds is not limited solely to the PLGA 
and chitosan system.  The central polymer film could be created by any desired method, 
and the outer layers could be added provided the solvent does not dissolve the central 
layer.  Additional studies utilizing other polymers such as PCL and gelatin, should be 
performed.  For example, a scaffold containing low molecular weight PCL and gelatin 
would provide faster degradation.  Scaffolds containing PCL and a blend of chitosan and 
gelatin could possibly improve bioactivity.  It may also be possible to form a two layer 
asymmetric matrix.  Biological activity could be enhanced by using either gelatin or 
blended chitosan/gelatin hydrogels instead of the 3D porous chitosan.  The system could 
also be modified for use in layer by layer microfabrication.  Standard photolithographic 
methods which enable more precise control of the perforation pattern could also be used 
to fabricate composite scaffolds263.  
3.6. Summary 
In summary, the composite design retains both the desirable mechanical 
properties of synthetic polymers and the biological properties of natural polymers, and 
matches characteristics of SIS (Table 2).  The composite material lacks growth factors 
and other signaling molecules, therefore it would be useful to incorporate a nanoparticle 
system for controlled release into the material.  However, the composite shows tensile 
properties similar to SIS, demonstrates the capacity for cell colonization, undergoes 
substantial degradation after 8 weeks.  The composite scaffold shows significant potential 
for use in tissue engineering applications.   
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Table 2. Summary of composite structure properties. 
 Natural Matrices 
(SIS)3 
Natural 
Polymers77 
Synthetic 
Polymers16 
Composite 
Scaffolds16 
Mechanical 
Strength 
3 MPa 2 – 6 kPa 1 – 9 MPa 3.5 – 5 MPa 
Degradation 
Time 
4 weeks 6 – 12 months 4 weeks 8 weeks 
Cellular 
Support 
Yes Yes No Yes 
Growth 
Factors 
Yes No No No 
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Chapter 4 
Local Mass Transport Properties
4.1 Nanoparticles in Tissue Engineering 
An important factor in tissue growth and development is the presence of cellular 
signals.  As discussed previously, one of the key advantages of natural matrices is that 
they already contain growth factors and other signaling molecules.  Growth factors, such 
as vascular endothelial grow factor (VEGF) and basic fibroblast growth factor (bFGF) are 
important for cell colonization, growth differentiation, and vascularization.  Therefore, it 
would be advantageous to incorporate growth factors into polymeric scaffolds.  However, 
growth factors are proteins with short half lives, the half life of bFGF is only 45 minutes 
in vivo264. Growth factors must be protected from denaturation until they are released into 
the body.  Because of this short half life, freely injected growth factor do not illicit an 
adequate healing response, but sustained release of the growth factor may lead to 
accelerated tissue regeneration265.  One method of incorporating growth factors is to use 
degradable particles as delivery vehicles.  A variety of controlled release particle systems, 
varying in size from micro (1-10 µm) to nano (<1000 nm, but typically under 200 nm) 
scale 266, 267, have been widely studied for cellular encapsulation76 and drug delivery 
applications268.   
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Nanoparticles and other nanostructures materials have been used in a variety of 
aspects in tissue engineering 269, 270.  Nanoparticles can be formed using several methods 
including double emulsion systems 271, emulsion polymerization 272, droplet formation273, 
or ionic condensation 274, 275, and have been used for controlled delivery of drugs or 
bioactive molecules.  Degradable particles capable of controlled release have been 
created from chitosan274-276, PLGA 268, 277, and gelatin 265, 278.  For example biodegradable 
poly(lactic-co-glycolic) acid (PLGA) nanoparticles (NPs) have been manufactured using 
double emulsification–solvent evaporation method and used as a vehicle for delivering 
various bioactive molecules including nucleotides 279-281, and drugs 282-284 for therapeutic 
purposes 285-287.  Controlled release particle technology been used to incorporate a variety 
of growth factors important for angiogenesis, wound healing, and bone growth288 as well 
as dental, oral and craniofacial applications 289. 
Particles can be loaded for release either during fabrication, or by absorption of 
proteins after the particles are created.  The growth factors can be encapsulated in 
nanoparticles and then released by diffusion through the polymer matrix 290 or through 
expulsion of the growth factor using particle expansion291, particle bursting 292, or surface 
erosion 293.  Nanoparticles can degrade via a wide variety of mechanisms, including 
surface erosion and bulk degradation.  Surface eroding materials degrade via a surface 
initiated mechanism and degrade one layer at a time, providing a uniform release profile.  
Bulk erosion typically leads to a delayed release of the drug, providing a high 
concentration release at one time point.  Bulk degrading materials degrade at all points of 
the material, often leading to the centers of the particles degrading faster then the edges.  
This is most prevalent in synthetic polyesters such as poly (lactic-co-glycolic acid) 
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(PLGA), which degrade by hydrolysis, and have acidic degradation products.  Therefore 
the pH within the particle lowers the particle degrades, catalyzing faster degradation of 
the particle294, 295.   
After loaded nanoparticles are produced, there are several ways to include them in 
the scaffolds. In one configuration the particles are concentrated at one point within the 
scaffold.  As the particles release their growth factors a concentration gradient forms with 
the maximum concentration at the particles.  However, particles have other useful 
properties which affect the properties of tissue engineering materials.  Particles can be 
used to modify the 3D structure of tissue scaffolds and thus alter their transport 
properties.  If nanoparticles are entrapped in a porous material they will block small 
porous features and can change the material’s transport properties.  For example, latex 
particles have been used to lower the permeability to urea of SIS 277.  Other nanomaterials 
such as hydroxyapatite296 and carbon nanotubes 297 have been used to physically reinforce 
scaffold matrices as well as provide specific 3D structural properties. 
Nanoparticles have been developed to target specific tissues and areas of the 
body.  Nanoparticle delivery can be controlled by modifying the surface to include 
specific marker and adhesion proteins.  For example particles which display RGD 
binding proteins on their surface specifically target endothelial cells and reduce 
angiogenesis 298.  Additionally, the magnetic properties of specialized nanoparticles can 
be used direct particles to specific sites non-invasively using magnetic fields 299.  Some of 
the key weaknesses of magnetic particles are biocompatibility and the ability to control 
the quality of magnetic particles, their size distribution, their shape and surface.  
However, research into surface coatings has improved the quality of magnetic particles 
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299
.  The magnetic particles are surface modified with RGD binding sites and arranged by 
magnetic fields.  Then the cells attach to the pattern determined by the particles 300.   
Another method to target drug or growth factor release is through particle 
mediated heating of temperature sensitive materials.  Nanosize particles within the matrix 
can be used to induce temperature changes thereby releasing a desired payload, causing a 
phase change or thermal expansion, or modifying the material’s 3D architecture301.  
Several techniques exist to selectively heat particles including light induced heating of 
gold particles292 and subjecting magnetic nanoparticles to alternating magnetic fields299.  
This heating may also be used to degrade and remove harmful elements from the body 
such as amyloid plaques common in Alzheimer’s patients302.  The heat generated can also 
be utilized to selectively kill cancer cells303.   
In living systems the nanoparticle itself must be biocompatible and non-toxic.  
However, when placed in a biological system the particles are rapidly coated with a layer 
of proteins.  Therefore, the particle is identified in the system not by its own surface but 
by the protein corona on its surface 304.  Therefore it is also important to study the 
adsorption of proteins onto the particle surface. 
However, particles have other useful properties which affect the properties of 
tissue engineering materials.  Particles can be used to modify the 3D structure of tissue 
scaffolds and thus alter their transport properties.  If nanoparticles are entrapped in a 
porous material they will block small porous features and can change the material’s 
transport properties.  For example, both PLGA and latex particles have been used to 
lower the permeability to urea of SIS 109.  Other nanomaterials such as hydroxyapatite296 
and carbon nanotubes 297 have been used to physically reinforce scaffold matrices as well 
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as provide specific 3D structural properties.  By altering the microarchitecture of SIS we 
sought to lessen the sample to sample heterogeneity in order to improve the consistency 
of tissue regeneration using nanotechnology. 
In this study, we investigated the possibility of modifying both SIS and the 
multilayer composite structure using a variety of nanoparticles made from polystyrene 
latex, PLGA, PLGA-HA, and chitosan. Modifications to the microstructure of both SIS 
and the composite were measured using scanning electron microscopy.  Additionally, the 
change in the transport properties across SIS was characterized by the change in 
permeability of urea.  The permeability was decreased based on both the size and number 
of particles present.  NPs did not alter the mechanical properties of the SIS, and the both 
NP modified SIS and composite continued to support cell adhesion and proliferation; and 
cell growth was significantly higher in PLGA NP modified SIS as compared to the 
unmodified SIS. 
4.2. Materials and Methods 
4.2.1. Sources of Material 
PLGA with a 50:50 monomer ratio, molecular weight of 106 kDa, and viscosity 
of 1.05 dl/g was purchased from Absorbable Polymers International (Pelham, AL). 
Negatively charged polystyrene latex spheres (six sizes between 50 nm and 2000 nm), 
urea, poly(vinyl alcohol) [PVA], poly(ethyleneimine) [PEI], and MCDB cell culture 
medium were obtained from Sigma–Aldrich (St. Louis, MO). Single layer SIS 
(Surgisis®) was obtained from Cook® Biotech (West Lafayette, IN). Chloroform was 
purchased from EMD Chemicals (San Diego, CA). Urea assay kit was purchased from 
Diagnostics Chemicals Limited (Oxford, CT). Fetal bovine serum (FBS) and penicillin–
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streptomycin were obtained from Invitrogen (Carlsbad, CA). Human mammary 
endothelial cells (HMEC-1) were provided by Dr. Mike Ihnat at the University of 
Oklahoma Health Sciences Center305.   
4.2.2. Synthesis of PLGA NPs 
Both PLGA nanoparticles and nanoparticles formed by conjugating PLGA and 
hylauronic acid (PLGA-HA) were a gift from Mr. Fadee Mondalek and Dr. H-K Lin from 
the University of Oklahoma Health Sciences Center, Department of Urology.  PLGA NPs 
were synthesized using a modified double emulsion solvent evaporation technique 306.  
Briefly, 30 mg of PLGA was first dissolved in 1 ml of chloroform. An aliquot of 200 µl 
of 7% PEI (used to produce positively charged nanoparticles) was added to the 
PLGA/chloroform solution followed by sonication on ice with a probe sonicator (model 
VC60; Sonics & Materials, Danbury, CT) set in a continuous mode for 30 s at 100% 
amplitude. The primary emulsion was transferred into 10 ml of 1% PVA; and the entire 
solution was sonicated on ice for another 1 min. The organic solvent in the final solution 
was allowed to evaporate overnight with continuous stirring. PLGA NPs were recovered 
by centrifugation at 30,000 × g for 20 min at 4°C. The pellet consisting of aggregated 
NPs was weighed and washed three times with water to remove any residual PVA. PLGA 
NPs were then resuspended in water using sonication to obtain a final concentration of 2 
mg/ml. The NPs were either used immediately or freeze-dried and then stored at −80°C 
for later use. 
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4.2.3. Forming Chitosan Nanoparticles 
Chitosan nanoparticles were created using ionic condensation 275, 307.  In brief, 300 
µL of 0.93 mg/mL sodium tripolyphosphate (TPP) solution was added to 700 µL of 1.8 
mg/mL high molecular weight chitosan solution containing 0.1% (v/v) acetic acid under 
sonication.  Fluorescent particles included 50 µL of 0.5 mg/mL fluorescein 
isothiocyanate (FITC).  Particles were centerfuged at (14,000 rpm), washed with water 
three times, and used immediately. 
4.2.4. Characterization of Nanoparticles 
Particles were assessed for the particle size, polydispersity index, and zeta 
potential using diffraction light scattering Zeta PALS (Brookhaven Instruments, 
Holtsville, NY) at room temperature.  Viscosity and refractve indices were set equal to 
those specific of water.  Particle concentration was measured using a FACSCalibur flow 
cytometer (Becton–Dickinson, San Jose, CA). For this purpose, synthesized NPs were 
diluted in water at four different concentrations. Particle concentrations were calculated 
using a calibration curve developed using commercially available latex particles with 
four different known concentrations. 
4.2.5. Microarchitecture analysis of nanoparticle modified structures 
SIS was cut into 1.2 cm × 1.2 cm pieces and assembled in 1.5 ml Eppendorf tubes 
between the lid and the tube with mucosal side facing upwards. NPs were loaded onto the 
mucosal side of the SIS inserts. The inserts were incubated overnight at room temperature 
with a constant shaking on an orbital shaker. To evaluate the microarchitecture of the NP 
modified SIS, the modified biomatrix was dehydrated using increasing concentrations of 
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ethanol followed by a brief vacuum drying. Samples were then sputter coated with a 15 
nm thick layer of gold at 40 mA and analyzed using an SEM (Joel scanning microscope). 
4.2.6. Particles integrated into composite structure 
PLGA/chitosan composite structures were formed as discussed previously.  The 
composite was cut into 2 cm x 2 cm pieces and six pieces were secured to Teflon plates 
with silicon glue.  Silicon wells were then formed as described previously.  After the 
silicon dried the composite structure was neutralized with ethanol and rinsed with water.  
Then 1 mL of appropriate nanoparticle solution (2000 nm latex, 500 nm latex, PLGA, 
PLGA-HA, and chitosan particles, as well as a control without particles) was added to 
each well.  The plates were then immersed in water and the particles were allowed to 
settle overnight.  Finally the structures were air dried, sputter coated with a 15 nm thick 
layer of gold at 40 mA, and analyzed using an SEM (JEOL scanning microscope).   
4.2.7. Characterization of properties of PLGA NP modified SIS 
SIS was converted into wells constructed using silicone glue on the mucosal side; 
and PLGA NP suspensions with the concentration of 1.273 mg/cm3 were added onto the 
mucosal side of SIS. The assembly was placed on an incubator shaker at 37°C overnight. 
The NP modified SIS membranes were rinsed with water to remove unattached NPs. The 
thickness of the NP modified SIS was measured using our previously described method3.  
Briefly, the NP modified SIS membranes were cut into small (2 mm × 10 mm) strips. 
Digital micrographs of the cross section were recorded using an inverted microscope 
equipped with a CCD camera. The cross section distances were measured using Sigma 
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Scan Pro software (Systat Software, Inc., Point Richmond, CA) which was calibrated 
using an image of a hemocytometer.  Tensile properties were then determined by our 
previously described method 110, 308. In brief, , 6 cm × 1 cm strips of NP modified SIS 
membranes were cut from each sample and analyzed using an INSTRON 5842 
(INSTRON Inc., Canton, MA) with a constant crosshead speed of 10 mm/min. Tests 
were performed under hydrated conditions at 37°C using a custom designed chamber. 
4.2.8. Urea permeability studies of NP modified SIS 
Permeability was analyzed using the apparatus built in-house as previously 
described 308. Briefly, latex spheres and PLGA NPs were suspended in phosphate 
buffered saline (PBS), and placed on the mucosal side of SIS placed in the permeability 
chamber.  NPs were allowed to settle onto the SIS through gravity on an orbital shaker at 
37 C overnight. The NP modified SIS membranes were washed three times with PBS in 
the chamber, and filled with 550 mm urea (typical concentration at physiological 
conditions) in PBS.  PBS was then added to the serosal side of SIS in the second 
chamber.  Aliquots of samples (20–50 µl) were collected from the second chamber 
between 0 min and 2 h. Samples collected immediately after the assembly of the 
chambers were used as time-zero values (i.e. C2 at t = 0). Concentrations of urea were 
determined using a urea assay kit (Diagnostic Chemicals Limited, Oxford, CT). 
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Membrane permeability was calculated as described previously 308. In brief, the 
following equation is obtained using a quasi-steady state approximation 
tP
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where C2 is the concentration of the urea measured at any time t in chamber 2, C0 (550 
mM) is the initial concentration in chamber 1, Am is the membrane area (3.1416 cm2 as 
the radius of the chamber is 1 cm), V is the volume of each chamber (4 ml), and P is the 
permeability of the matrix. Then ln(C0−2C2)/C0 was plotted as a function of time from 
which the slope ((AmP)/V) was determined using a linear fit. The permeability was 
calculated using the slope values. 
4.2. Statistical analysis 
Statistical differences between two experimental groups were evaluated using 
student's t-test. A statistically significant difference was considered when p < 0.05. 
4.3. Results 
4.3.1. Characteristics of synthesized NPs 
The average diameter of synthesized PLGA NPs ranged between 162 nm and 306 
nm. Polydispersity indices varied from batch to batch, but the value was approximately 
constant at 0.06. The zeta potential ranged between +40 mV and +50 mV, depending on 
the batch of PLGA NPs synthesized. The morphology of the PLGA NPs as assessed by 
the SEM showed a porous outer surface (data not shown). The concentration assessment 
by flow cytometry indicated that 1 mg/ml PLGA NPs suspended in water generated 1.62 
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× 108 particles/ml.  PLGA-HA particles averaged a diameter of 1300nm with a 
polydispersity of 0.3 and a zeta potential of -12 mV.  Chitosan particles had a diameter of 
270nm, a polydispersity of 0.25, and a zeta potential of 33 mV. 
4.3.2. Surface structure of NP modified SIS 
Commercial nominally monodisperse polystyrene latex spheres (sizes between 50 
nm and 2000 nm) were used to determine appropriate sizes of NPs to embed within SIS 
in order to reduce permeability to urea. Latex spheres with diameters ranging between 
200 nm and 500 nm appeared on both mucosal and serosal sides of SIS (Figure 19 C, C′–
E, E′). In contrast, larger sizes (1000 nm and 2000 nm) of latex spheres were 
predominantly present on mucosal side of SIS (Figure 19 A, A′, B and B′), whereas 
smaller size (50 nm) latex spheres were not observed on either side of SIS (Figure 19 F 
and F′). These results suggested that NPs smaller than 200 nm could not be retained in 
SIS; and NPs larger than 500 nm could not fit into the porous structure of SIS.
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Figure 19. SEM images of latex spheres modified SIS.   
Mucosal sides of SIS were imaged following overnight embedding of 2 µm (A), 1 µm 
(B), 500 nm (C), 300 nm (D), 200 nm (E), and 50 nm (F) latex spheres. Serosal sides 
of the same SIS membranes were also imaged (A′–F′). 
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To determine whether PLGA NPs also possessed similar characteristics as latex 
spheres, two sizes of PLGA NPs (162 nm and 306 nm) were placed onto the SIS. SEM 
images demonstrated that both sizes of PLGA NPs (Figure 20) went through the SIS 
similar to latex spheres. However, less NPs with 162 nm in size (Figure 20B) were 
retained on the mucosal side of SIS as compared to the serosal side (Figure 20B′). 
Furthermore, more NPs with 306 nm in size were retained on the mucosal side (Figure 
20C) relative to serosal side (Figure 20C′). Nevertheless, these results confirmed that NP 
sizes ranging between 200 nm and 500 nm would be appropriate to fit into the porous 
structure of SIS.  
 
Figure 20. SEM images of PLGA NP modified SIS.   
Unmodified SIS was imaged on mucosal side (A) and serosal side (A′). Following 
162 nm PLGA NPs embedding, mucosal side (B) and serosal side (B′) of the SIS 
structure were shown. Panels C and C′ show SIS modified by 306 nm PLGA NPs on 
mucosal and serosal sides of SIS, respectively. 
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4.3.3. Particles integrated into composite structure 
Next particles a variety of particle types were integrated into the composite 
matrix.  Because of the mechanical interlocking through the composite particles can only 
be integrated one side at a time.  However, particles are clearly visible, showing that they 
can be incorporated into the composite structure (Figure 21).
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Figure 21. Particles integrated into the composite structure. 
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4.3.4. The effect of NPs on SIS permeability 
NP modified SIS had reduced permeability as compared to unmodified SIS 
(Figure 22A). The permeability was 1.13×10−3 cm/s in unmodified SIS as compared to 
7.71×10−4 cm/s in SIS embedded with 200 nm latex sphere. The permeability was 
reduced further to 6.53×10−4 cm/s when 300 nm latex spheres were used as compared to 
unmodified SIS. When 500 nm latex spheres were used, urea permeability did not show 
significant reduction from that of unmodified SIS.  
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Figure 22. Alteration of SIS permeability to urea by NPs.   
Permeability chambers were set up by placing latex spheres (A) or PLGA NPs (B) 
on the mucosal side of SIS to demonstrate size-dependent and concentration 
dependent permeability, respectively. Zero size or zero concentration indicates 
permeability measured with unmodified SIS, i.e. no particles. Results are present as 
mean ± standard deviation from three independent experiments. * Indicates that 
these results were different vs. unmodified SIS (p<0.05). 
*
*
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The permeability of the SIS to urea was then measured after introducing 260 nm 
PLGA NPs to SIS. Three different concentrations, 0.1 mg/ml, 1.0 mg/ml, and 5.0 mg/ml 
of PLGA NPs, were used to determine concentration dependent changes in permeability. 
The permeability was significantly reduced to 5.63×10−4 cm/s when 1.0 mg/ml PLGA NP 
was used to embed SIS as compared to either 0.1 mg/ml or 5.0 mg/ml PLGA NPs 
(Figure 22B). 
4.3.5. The effect of NPs on SIS mechanical properties 
To assess the effect of embedding NPs into SIS on its mechanical properties, 
tensile properties of PLGA NP modified and unmodified SIS were compared. These 
results showed no significant difference in break stress or break strain (Figure 23). In 
addition, when elastic modulus was calculated in the linear range (10–20% strain range), 
no significant difference was detected between NP modified SIS and unmodified SIS. 
Both samples showed elastic modulus of 26 MPa, similar to our previous results3. 
However, the thickness of wet SIS in this study averaged 110 µm ± 21 µm as compared 
to 246 ± 16 µm in our previous study.  
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Figure 23. Stress–strain curves of SIS with and without PLGA NPs. 
4.4. Discussion 
As noted in chapter 3, SIS has been intensively investigated for its capability in 
tissue repair and regeneration in a variety of tissues and animal models in the last 20 
years. SIS has been shown to be a promising biomaterial for tissue regeneration because 
it is formed from extracellular matrix elements and contains growth factors and other 
cellular signals that may promote cell migration, growth, and differentiation 309.  
Therefore, one way to improve the composite polymer structure and better approximate 
the characteristics of SIS is to incorporate a mechanism for the controlled release of 
growth factors and other cellular signals into the polymer matrix.  Additionally, 
numerous attempts have been made to produce “off-the-shelf” SIS products that would be 
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available for clinical reconstructive surgical procedures 56, 310-312.  However, SIS suffers 
from inconsistent results in various applications. These inconsistencies may result from 
heterogeneities inherent in natural matrices 308.  The presence of a controlled release 
delivery system will affect the transport properties of the material.  One such delivery 
system utilizes nanoparticles to deliver the cellular signals.  These particles may embed 
themselves into the porous structure and reduce the permeability of the system.  
Therefore, incorporating the nanoparticle system into SIS may reduce the sample to 
sample heterogeneity in the system.  A more consistent material may improve the 
consistency of tissue regeneration. 
Because SIS is a decellularized natural matrix, the pores in the SIS are neither 
uniformly distributed, nor are they uniform in size 308.  They vary in size from pores that 
were previously blood vessels to tiny spaces between collagen fibers.  Additionally, the 
porous structure changes across the thickness of the SIS.  For example permeability of 
urea across the serosal side of SIS is greater than across the mucosal side 3.  This large 
pore size distribution explains the wide size ranges (200 nm – 500 nm) of particles 
capable of embedding themselves in SIS.  The absence of small size NPs (50 nm) within 
SIS in the SEM images may be because the 50nm particles traveled completely through 
the porous matrix without embedding themselves, or it may be an artifact of the 
characterization techniques employed.  First, the 15 nm gold used for coating during 
SEM procedures may make the particles difficult or impossible to be distinguished from 
the SIS, and visualizing the 50 nm latex particles on SIS may be beyond the resolution 
limitations of the SEM.  It is also important to note that SIS differs from batch to batch 
from the same manufacturer.  For example, in 2005 we reported Cook SIS thickness as 
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101 µm ± 19.84 µm (dry) and 246 µm ± 16.22 µm (wet)3.  In the present study (2007), 
thickness of the Cook SIS was 29.6 µm ± 6.4 µm (dry) and 110 µm ± 21 µm (wet) 277.  
Based on the inconsistency of the SIS and the wide variation in pore size, a combination 
of different sizes of NPs might ultimately be needed to achieve maximal uniformity of 
SIS.  Additionally, further experiments by our collaborators confirmed that the modified 
SIS supports cellular colonization of endothelial cells277. 
Permeability studies indicated that there was no statistically significant difference 
between the unmodified SIS and 200 nm latex spheres modified SIS, or between the 
unmodified SIS and 500 nm latex spheres embedded SIS. In contrast, a significant 
difference was detected between the unmodified SIS and 300 nm NP modified SIS.  It 
appeared that the 200 nm NPs plugged some of the SIS pores as observed in the SEM 
images (Figure 19), and perhaps resulted in a slight reduction in permeability.  However, 
the particles may not fill a critical number of the pores to provide a statistically 
significant reduction in permeability.  The same explanation can be applied to 500 nm 
NPs.  In contrast, 300 nm latex spheres seem to fill enough number of pores in SIS to 
provide a significant reduction in permeability.  It may also be possible to further reduce 
the permeability of SIS if a combination of different sizes of NPs is used for SIS 
modification. 
To determine the minimal concentration of PLGA NPs that can modify SIS, 260 
nm PLGA NPs were used in urea permeability assays.  With 1 mg/ml PLGA NPs, the 
permeability was reduced significantly as compared to unmodified SIS.  The failure of a 
higher concentration, 5 mg/ml, to significantly reduce SIS permeability might result from 
aggregation of this concentration of PLGA NPs; and these aggregates were too large to fit 
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into the porous structure of SIS and hence could not reduce SIS permeability as seen with 
larger sizes of latex spheres (1 µm and 2 µm). 
Reduction in SIS permeability may be a critical factor in determining the success 
of tissue repair and regeneration especially in bladder regeneration.  Based on our 
observation, proximal sections of SIS are more permeable to urea than distal sections of 
SIS 308, and have not been successful for bladder regeneration2. The leakage of urine in 
augmented bladder can have detrimental effects on inflammatory responses during the 
process toward complete regeneration, and may result in the absence of bladder 
regeneration as we reported in a dog bladder augmentation model2. We expect that the 
reduction in permeability in NP modified SIS may significantly improve tissue 
regeneration processes particularly in urinary bladder regeneration. 
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4.5. Conclusion 
A nanoparticle system with the potential for controlled release of bioactive 
molecules has been developed in order to better mimic the properties of SIS in a polymer 
system.  The nanoparticles integrate nicely into the composite as shown by SEM. 
However, the addition of particles into the system could affect the material transport 
properties.  Therefore the change in transport properties was studied by incorporating the 
nanoparticle technology into SIS.  The particle technology has potential to decrease the 
heterogeneity of SIS, is a major issue in producing consistent tissue repair and 
regeneration.  The particle system can alter the permeability of the SIS without affecting 
the mechanical or biological properties of the system.  Future work should focus on 
adding the controlled release element to particles for the polymer system and optimizing 
the particle embedding methods in order to achieve more a more consistent SIS material.  
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Chapter 5 
Forces and Flow Dynamics in In Vitro Bioreactors
5.1.  Bioreactor Overview. 
Bioreactors have been widely utilized for regenerating tissues in vitro.  
Maturation in bioreactors is an important aspect of tissue engineering.  Currently, only a 
small cross section of tissue engineering materials can be used clinically without prior 
cell seeding 2.  Other materials require that cells be incorporated into the porous structure 
before being used for tissue engineering.    
The bioreactor configuration is becomes important during in vitro maturation cell 
seeded scaffolds.  Maturation in reactors ensures sufficient nutrient transport through cell 
seeded porous scaffolds 123, 313.  Using bioreactors, an improvement in the quality of the 
regenerated tissue is observed in some studies 314.  However, other studies show 
deterioration in the quality of the tissue 315.  Flow of growth medium improves nutrient 
and waste transport, but alterations in the synthesis of matrix elements induced by shear 
stresses could deteriorate the tissues 316.  Nutrient transport also becomes important in 
composite systems.  Modifications to the porous structure in order to increase mechanical 
strength will most likely create a barrier to mass transport16. 
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Most studies utilize small scale cylindrical or discoid scaffolds, focusing on wall 
shear stresses 317.  However, flow within bioreactors containing large porous structures 
with high aspect ratios has not been studied.  In these scale-up systems, non-ideal fluid 
distribution conditions could arise from two possible factors: channeling, and dead zones.  
When channeling is present, some of the fluid leaves the reactor immediately without 
dispersing within the reactor.  Dead zones reduce the effective volume of the reactor and 
prolong the residence time of some of the fluid elements.  Non-uniform flow patterns 
within the reactor could lead to i) poor distribution of nutrients and ii) non-uniform shear 
stress distribution.  These factors affect cellular colonization, proliferation, and the 
assembly of extracellular matrix elements which affect the quality of regenerated tissues.  
Hence, one has to understand the fluid distribution and the effect of shape of the reactor.   
Some cell types respond to mechanical stress and change the tissue structure and 
composition to meet the functional demands.  There are two primary modes used to 
subject the scaffold materials to mechanical forces.  First, the scaffolds can be 
mechanically strained utilizing by pushing or pulling on the material 318, 319.  This 
mechanical extension or compression offers good control over the range and direction of 
forces that materials are subjected to.  However, he need for a both a method to grip the 
scaffold and to control the applied forces complicates the design of the reactor adding to 
the cost.  The other main method used to control the mechanical forces that cells are 
exposed to is through fluid shear stress.  Hence, fluid flow within the reactor can be 
utilized as a way to introduce mechanical stresses to cells 320.  The interaction of fluid 
with a surface creates a shear stress upon the surface.  The shear stress becomes 
especially important in cell seeded porous matrices because the cells see the shear within 
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the individual pores.  The pore shear stress can also change during the process of cellular 
regeneration.  As the cells colonize the material they produce both more cells and they 
remodel their local microenvironment by producing extracellular matrix (ECM) elements 
as the porous scaffold material degrades away.  Additionally, shear stress affects the 
scaffold architecture as well as cellular alignment within the structures 5, 125. 
There are several types of reactors commonly utilized in tissue engineering313, 320.  
One of the simplest reactor configurations is a spinner flask.  A spinner flask batch 
reactor where the cell seeded construct is placed into standard cell culture flask and 
agitated by a mechanical stir bar321.  Spinner flask design can be modified to better 
control the flow profile within the reactor.  The scaffolds can be anchored to either the 
flask or the stirrer 322, and in one alternate design a wavy walled flask is used to create 
better mixing conditions 323.  Another popular reactor design developed by NASA utilizes 
rotating reactor walls in order to grow cellular constructs in simulated microgravity 324.  
Rotating wall bioreactors consist of two concentric cylinders with their lengths parallel to 
the ground.  The outer cylinder rotates pulling the fluid and scaffolds up over the inner 
tube and then the scaffolds free fall until they are pulled up and over again.  The scaffold 
movement provides the driving force for nutrient transport within the porous matrix.  
Other rotating designs include disk reactors that rotate perpendicular to the ground with 
scaffolds anchored to the center tube 325.  Perfusion reactors are designed to force fluid 
through the porous matrix326.  They come in a variety of configurations including hollow 
fiber and radial perfusion systems327.  Some anchor the scaffold material to frames and 
place several immobilized scaffolds into the fluid flow328.  Other designs allow the 
scaffold to be free floating adjust the flowrate to keep the scaffold suspended in the fluid 
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column 329.  Perfusion reactors may also be built in a parallel plate configuration where 
the walls of the reactor constrain the scaffold and force the flow through the porous 
matrix 318. 
To better understand the effect of fluid flow during tissue regeneration, a number 
of studies using computational fluid dynamics (CFD) have been performed 325, 330-334.  
The majority of these studies assess the flow patterns and shear stresses either within the 
bioreactor or around the porous construct 325, 335.  Additionally, some studies do not 
account for porosity or transport through the scaffold.  They treat the scaffold as an 
impermeable solid instead of a porous region325, 336.   
Flow characteristics are analyzed using either Darcy’s equation 337, or the 
Brinkman equation which is considered as an extension of Darcy's equation 338.  The 
Brinkman equation accounts for both viscous and drag forces in the porous medium and 
reduces to either the Navier-Stokes equation or Darcy’s law if either force becomes 
dominant 339.  However, porous characteristics change during tissue regeneration, i.e., 
permeability of the matrix decreases due to decreased pore size.  Further, many tissues 
(for example cartilage and bladder) have a high aspect ratio (large surface area relative to 
the thickness of the matrix).   
The non-ideal fluid distribution is characterized using the residence time 
distribution (RTD).  The RTD measures the amount of time different molecules present 
in the fluid spend within the reactor 340, 341.  In other words, RTD is a measure of 
dispersal of a molecule in a flowing medium owing to the combined action of a velocity 
profile and molecular diffusion.  Understanding these characteristics is important in 
designing the reactor shape and optimizing the location of the inlets and outlets.   
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This study utilized a well understood perfusion reactor with a parallel plate 
configuration 5, 342 and evaluated the effect of porous structure in the flow domain.  The 
parallel plate reactor with three different inlet and outlet conditions was simulated using 
CFD packages CFX 11 (ANSYS Inc, Canonsburg, PA.) and/or Comsol Multiphysics 3.4 
(COMSOL, Inc., Burlington, MA).  Further experiments were performed to validate the 
simulation results.  These results show significant increase in pressure drop when the 
porous characteristics are modified. 
5.2. Materials and Methods. 
5.2.1.  Sources of Materials 
Chitosan with >310 kDa MW and 85% degree of deacetylation, glucose, sodium 
bicarbonate,  Dulbecco’s modified Eagle medium (DMEM), and glacial acetic acid were 
obtained from Sigma Aldrich Chemical Co (St. Louis, MO).  Ethanol (200 proof) was 
obtained from Aaper Alcohol and Chemical Company (Shelbyville, KY).  All other 
reagents were purchased from Fisher Scientific (Waltham, MA).   
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5.2.2.  Obtaining RTD function using CFD:  
One basic reactor geopetry was uses (8 cm long, 2.5 cm wide, and 0.2 cm high, 
with a 0.1cm inlet and outlet diameter).  For each shape, three inlet and outlet 
configurations (Figure 24) were chosen to understand the effect of inlet and outlet 
locations and design on flow patterns.   
 
Case 1: with abrupt inlet and outlet to demonstrate non-ideal mixing. 
Case 2: with long entrance and exit section to facilitate fully developed laminar flow.  
Case 3: with inlet and outlet from the top.  This configuration is commonly used in a 
variety of cell studies such as shear effect on endothelial cell, neutrophile sequestration, 
and long term bone marrow cultures 5, 343.   
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Figure 24. Schematic of reactor designs utilized in this study showing major dimensions 
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These reactor geometries were created using a CAD package (SolidworksTM or 
ANSYS Workbench 11).  The CFX mesh was then created using ANSYS CAD2Mesh 
software.  A critical challenge was overcoming problems associated with the aspect ratio 
i.e., very large surface area relative to the thickness of the channel.  To ensure at least 10 
nodes over the thickness of the reactor, the maximum element size of 0.2 mm was 
chosen.   
Preliminary simulations used a water mass flowrate that corresponds to the 
average wall shear stress present in human blood vessels, 2.6 g/s (156 mL/min) 5.  Flow 
rates of 0.33 g/s (20 mL/min) and 0.0825 g/s (5 mL/min) were used for later simulations 
and experimental validation because higher flowrates compressed the porous structure.  
The simulation was run at steady state in order to visualize flow distributions and to 
generate the initial velocity profile for transient simulations.  The outlet was set at 
atmospheric pressure and the walls were smooth with no slip condition.   
Residence time distributions (RTDs) were obtained by introducing a tracer into 
the reactor feed starting at time equal to zero seconds.  The tracer for the simulations was 
created as a duplicate fluid based on water and then renamed as tracer.  This created a 
tracer with the same physical properties as that of water.  The tracer was introduced as a 
step change in the concentration (represented as C0).  The values for steady state flow of 
water were used as initial conditions.  Then, the inlet fluid was switched from 100% 
water to 100% tracer at time equals zero seconds.  The simulations were run using 0.05 s 
time-steps until the concentration of tracer was at least 0.98 (300 steps, 15 s), with 
transient results written every 0.1 s.  The RTD is obtained by applying a step change in 
the concentration of a tracer flowing into the reactor (represented as C0) and evaluating 
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the temporal volumetric flow-averaged tracer concentration at the reactor outlet.  The 
dimensionless mixing cup (or volumetric flow-averaged) tracer concentration (Cmix(t)) 
across the rectangular reactor outlet was evaluated using the equation 341  
( ) avg avgmix
avg
C V x z
C t
V x z
∆ ∆
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∑
∑
     (5) 
where Cavg is the average tracer concentration across between two finite elements and 
Vavg is the average velocity in the z-direction between those elements.  Cmix(t) is also 
measured tracer concentration from the experiments at a given time when collecting 
samples at the reactor exit.  Next the RTD function, E(t), was calculated for a positive 
step change in the tracer concentration using the equation 340 
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Additionally, the RTD function was converted to dimensionless time (Θ) in order to 
directly compare multiple geometries and flow rates.  The dimensionless form of the 
equation (E(Θ)) was calculated using the equation  
  
τ
t
=Θ          (7) 
where τ is the space time of the reactor i.e., the ratio of the volume of the reactor to 
volumetric flow rate. 
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5.2.3. Obtaining RTD using experimental setup.  
The RTD function was determined experimentally by introducing a red food dye 
as a step change in the inlet concentration.  A rectangular reactor similar to Case 3 
(length of 8 cm, a width of 2.5 cm, a height of 0.2 cm, and a 0.1 cm inlet and outlet 
diameter) was fabricated in-house from polycarbonates as shown in Figure 25A and 
Figure 25B.  The effective length and width of the reactor was based on the size of a 
standard microscope slide, and the height was based on the thickness of a porous matrix 
commonly used in our laboratory 16.  The reactor’s height and hexagonal flow field were 
maintained using a 2mm thick Teflon gasket.  
 
Figure 25. Reactor set-up used in experimentation.   
(a) Top view of the rectangular reactor. (b) Side view of the rectangular reactor. 
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The reactors were attached to a flow system consisting of two fluid reservoirs, a 
variable speed Masterflex L/S peristaltic pump (Cole-Parmer, Vernon Hills, IL), an in-
line physiological pressure transducer (Capto SP844, Capto, Skoppum, Norway), the 
bioreactor, and two waste reservoirs (Figure 26).  The pressure transducer was connected 
to a computer via Powerlab/4SP System (ADI Instruments, Inc., Colorado Springs, CO) 
and data were acquired through Chart™ 5 for Windows.  The tubing system for the 
reactor was designed in order to produce a step change in the reactor’s inlet 
concentration.  Two separate tubes were run through a peristaltic pump, one from a water 
reservoir and another from a reservoir filled with dye tracer solution.  These tubes each 
led to a three way stopcock (V1 and V2) that would send the fluid either towards the 
reactor or into a waste reservoir.  The two sides were connected by a T-joint, allowing 
dye solution or water to enter the reactor.   
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Figure 26. Flow system used in reactor experiments. 
 
Initially the flow loop was primed with the valve positions (V1 to dye waste and 
V3 to reactor) set so as the water traveled through the reactor while the dye solution was 
send to a waste container.  Water was run through the system for until steady state was 
obtained.  At time zero, V1 and V3 were changed simultaneously (V1 to reactor and V3 
to water waste) so the dye solution traveled through the reactor and water was sent to the 
waste container.  Fractions were collected in a 24 well plate at the reactor outlet over 
regular intervals.  Next 100 µL of each fraction was transferred to a 96 well plate and the 
absorbance was measured at 490nm; initial spectral scan over visible spectra showed that 
the maximum absorbance was at 490 nm wavelength.  The relative concentration 
(C(t)/C0) was calculated from the relative absorbance (A/A0)  
00
)()(
A
tA
C
tC
=
        (8) 
where A0 is the initial concentration of the dye solution.  The RTD function (E(t)) was 
calculated using Equation 6 as before.  Since 20mL/min flowrate compressed the porous 
scaffold structure, 5mL/min was used.  For the rectangular reactor 20mL/min fractions 
were collected over 1 s intervals, and fractions for the 5 mL/s flow rate were collected 
over 5 s intervals.   
5.2.4.  Analytical Model Derivation. 
The RTD function for an ideal completely developed laminar flow with no slip at 
the boundaries was derived as another method of verifying simulation data for 
rectangular reactor 340.  The reactor was modeled as a set of parallel plates with a width 
(w) and a height (h) 344.  Side and end effects were ignored with the assumption of 
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completely developed laminar flow profile in the y-direction (direction of the reactor 
height).  The velocity in the z-direction was calculated from the volumetric flowrate (see 
Appendix 1 for detailed derivation of the equation). 
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The minimum residence time was calculated from the maximum velocity equation 
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Eq. (12) and Eq.(13) were used to generate E(t) curves for the ideal case.   
5.2.5. Preparation of porous structure. 
Porous structures of dimensions appropriate for each reactor were generated by 
freezing 0.5% (wt/v) chitosan solution prepared in with 0.1 M acetic acid at -80ºC, then 
lyophilized overnight (Virtis, Gardiner, NY).  The porosity and pore size distribution of 
these matrices in hydrated condition has been extensively characterized in our laboratory 
5, 14, 112
.  Scaffolds were stabilized in 100% ethanol and incubated in red-dye prior to use 
in experiments.  The pore size distribution and porous structure characteristics of the wet 
scaffolds were analyzed using light microscopy.  Prior to viewing under light 
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microscopy, chitosan structures were sectioned to view cross sectional architecture.  Pore 
size and number of pores was determined from digital micrographs using Sigma Scan Pro 
software (Systat Software, Inc., Point Richmond, CA).   
5.2.6. Simulation including the porous structure. 
Next, a porous medium was created within the reactor space to better understand 
the effect of porous structure on fluid flow, simulations were performed using COMSOL 
Multiphysics 3.3 (COMSOL inc, Burlington, MA).  Both the case 3 and case 6 
geometries were created in COMSOL using configurations identical to described above.  
Fluid flow through the porous structures was modeled using the Brinkman equation  
2
s su u p
µ
µ
κ
∇ − = ∇        (14) 
0=•∇ su         (15) 
where κ is the permeability of the porous medium, us denotes the fluid superficial 
velocity vector, p is the fluid pressure, µ the effective viscosity in the porous medium, 
and κ is the permeability of the porous medium 344.  Nonporous sections of the reactor 
were modeled as incompressible Navier-Stokes regions.  The permeability (κ) of the 
porous medium is a geometric characteristic of the porous structure at several length 
scales 344.  The permeability was calculated using 85µm and 120 pores/mm2 and the 
equation   
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4
128 A
n dπκ =        (16) 
where nA is the number of pores per unit area and d is the pore diameter assuming the 
pores to be circular in shape.  To understand the effect of pore size and number of pores, 
κ values were calculated for (Table 3 and Table 4) different pore sizes and pore 
numbers.  These values were used in the simulation.  Shear stresses within the reactor 
were calculated using the shear stress tensor .   
( )( )Tuu ∇+∇=ητ        (17)  
where η is the dynamic viscosity (Pa·s) and u is the velocity in the open channel (m/s).  
The shear stress tensor is an integral part of the Navier-Stokes equations describing flow 
in a free channel, at steady state, given by 
( )ijpuu δτρ +−•−∇=∇• )(       (18) 
0=•∇ u         (19) 
where η is the dynamic viscosity (Pa·s), u refers to the velocity in the open channel (m/s), 
ρ is the fluid’s density (kg/m3), ijδ is the Kronecker delta function, and p is the pressure 
(Pa).  Both the permeability (ĸ, m2) and void fraction (εp, dimensionless) were 
incorporated into Equation 18 in order to account for the porous characteristics of the 
matrix, yielding another form of the Brinkman Equation  
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The simulation was run at 5 mL/min (similar to experiments), with atmospheric 
pressure as the outlet condition.  From the steady state output results, the pressure drop 
and the maximum shear stress were determined across the porous subdomain.Further, the 
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shear stress was visualized as the viscous force per area in the z direction, as calculated 
by Equation 21. 
n•τ          (21) 
Table 3. Effect of pore size and pore number on pressure drop and shear stress. 
Pore Size 
(µm) 
Pores/ mm2 
 
k (µm2) 
 
Pressure Drop 
(kPa) 
Maximum Shear 
Stress (dyne/cm2) 
10 1500 0.368 238 0.228 
17.5 1050 2.42 36.4 0.227 
25 600 5.75 15.2 0.227 
37.5 450 21.8 4.02 0.224 
50 300 46 1.91 0.220 
85 120 154 0.57 0.207 
120 60 305 0.287 0.192 
150 35 435 0.202 0.181 
200 15 589 0.149 0.171 
 
Table 4. Effect of reduced pore size with constant pore number on pressure drop 
and shear stress. 
Pore Size 
(µm) 
Pores/mm2 
 
k (µm2) 
 
Pressure Drop 
(kPa) 
Maximum Shear 
Stress (dyne/cm2) 
85 120 154 0.57 0.207 
50 120 18.4 4.76 0.225 
37.5 120 5.82 15.1 0.227 
25 120 1.15 76.2 0.228 
17.5 120 0.276 318 0.228 
10 120 0.0295 2970 0.228 
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5.3.  Results and Discussion. 
5.3.1. Steady state profile in unpacked reactors. 
First, the streamline patterns for water flowing through the reactor without porous 
structures were analyzed in all the reactors at steady state.  For individual reactor cases, 
no significant difference in the streamline patterns was observed between 156 mL/min 
and 20 mL/min flow rates.  However, different reactor geometries showed significantly 
different streamline patterns.  In case 1 (Figure 27A), a number of recirculation zones 
were observed through out the reactor.  This could lead to a large dead volumes and a 
random orientation of cells.  Case 2 (Figure 27B) showed completely developed flow 
pattern without any recirculation in the entire length of the reactor.  In case 3 (Figure 
27C), recirculations were observed at the entrance of the reactor but the majority of the 
reactor shows laminar streamlines.  Differences in the flow distribution as a result of 
increased flowrate can be seen in Figure 28. 
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Figure 27. Steady state stream line profiles in different reactors simulated with a flow rate of 20mL/min. 
 
 
 
Figure 28. Steady state stream line profiles in different reactors simulated with a flow rate of 156 mL/min 
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5.3.2. Residence time distributions without porous structure  
Transient residence time distributions for the tracer were analyzed at the reactor 
outlet to better understand the flow distribution of nutrients.  First, the changes in the 
tracer concentration across the outlet diameter were examined so that a method to 
determine Cmix(t) from the simulation results could be developed.  For this purpose, tracer 
concentration across the reactor outlet was plotted (Figure 29).  Examination of these 
results showed that for 1 mm outlet diameter, the tracer concentration was virtually 
linearly distributed over the cross section area.  Examination of the tracer concentration at 
the reactor exit showed that case 1 had a relatively constant outlet concentration at each 
time point.  Similarly, case 2 also showed flat concentration profiles.  Initial and final 
concentration profiles were flat in case 3 at the initial time points which changed to linear 
variation across the outlet before reaching a flat profile.  However, it only took about one 
second for a complete changeover from water to tracer.  This suggested that for 
rectangular reactors approximating Cmix(t) using Equation 5 is valid.  
  
 
 
 
Figure 29. Concentration profiles at the reactor outlet for different times at the 20 mL/min flowrate.
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The relative concentration (Cmix/C0) was plotted against dimensionless time 
(Figure 30A and Figure 30C).  In case 1 and case 4 the tracer exited the reactor much 
sooner than in other geometries.  This premature exit of the tracer could be attributed to 
the dead volume or channeling.  Next, E(t) was calculated for different time steps and 
plotted as a function of dimensionless time (Figure 30B and Figure 30D).  All 
rectangular reactor peaks except case 1 aligned as expected at 2/3rd the ideal space time.  
Additionally, peak spreading was observed in case1, case 2, and case 3 indicating 
dispersion of the tracer or flow non-idealities.  Further, E(t) peak heights for case 1 and 
case 3 were higher than case 2.  These observations suggest that there are dead-spaces 
within the reactor in case 1 and case 3.  The simulation results for case 3 were validated 
by experiment.  The simulations and experiments had similar concentration and RTD 
profiles when plotted, showing that methodology is a valid approach to analyze flow 
properties in the reactor systems.   
   
 
Figure 30. of reactor shape on the residence time distribution of the tracer at 20 mL/min. 
a) Concentration of the tracer at the outlet of rectangular reactor.  b) E-curve for rectangular reactor.  
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5.3.3.  Effect of porous structure on flow distribution. 
This study utilized chitosan porous structures prepared by freeze drying at -80ºC.  
Chitosan was selected because i) it is optically transparent, enabling visual monitoring of 
the flow distribution, ii) the matrix will not degrade in the absence of enzymes, iii) its 
mechanical properties are well described, and iv) pore characteristics of the scaffold have 
been analyzed extensively 5, 14, 112.  Scaffolds formed by freezing at -80ºC showed an 
average pore size of 85 µm (± 20 µm), 120 pores per mm2, and a porosity of 85%.   
Porosity values were used to calculate the available reactor volume and space time. 
When RTD was examined for reactors containing the porous structure, results 
indicated (Figure 31) that the tracer exited the reactor sooner relative to conditions 
without the porous structure.  This could be attributed to the increased resistance to flow 
caused by the presence of the porous structure which could favor channeling.  When fluid 
entered the system, the hydrodynamic forces deformed the polymer scaffold, creating a 
shorter path to the outlet of the reactor.  While performing experiments, it was observed 
that the scaffolds were compressed near the inlet and the flow traveled over the top of the 
matrix and along the walls without significantly infiltrating into the porous structure.  
This bypass effect was minimized by providing space for entry and exit effects, thereby 
ensuring that the flow entered the porous structure instead of bypassing it.  
   
 
Figure 31. Effect of flow rate and porous structure on the residence time of the tracer. 
a) Concentration of the tracer at the outlet of rectangular reactor.  b) E-curve for rectangular reactor.  
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5.3.4.  Effect of changing pore sizes. 
Next, the pressure drop across the reactors and the shear stresses developed within 
the porous structures were assessed.  When fabricating scaffold the number of pores and 
the pores per area do not change independently.  For example, a matrix with smaller 
pores should have more pores in any given area then a scaffold with larger pores.  
Therefore, simulations were performed using various pore sizes and pores per area to 
better understand the effects of the porous architecture.  Values for pore size and pores 
per area were centered on an experimentally determined value (85 µm diameter pores and 
120 pores/mm2) (Table 3).  These results showed significant changes in the pressure drop 
across the bed for rectangular reactors.  The pressure drop increased when the pore size 
was reduced, and increased when the number of pores per unit area (pores/mm2) was 
increased.  Additionally, the pressure drop was inversely proportional to 1/κ as predicted 
by the Brinkman equation (Equation 14).  The experimentally measured pressure drop 
within the reactors was slightly higher than pressure drop predicted by the simulation.  
The pressure drop at the 5 mL/min flowrate was 2-5 mmHg (0.267 –0.667 kPa), which 
agreed with the simulation value.   
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In the rectangular reactors (Figure 32), the shear stress increased in a linear 
fashion as the pore size decreased, but that the shear stress increased exponentially as the 
pore density (pores/mm2) increased settling on a value of 0.228 dyne/cm2.  Flow within 
the rectangular reactor was in the z direction only; therefore, shear stresses for the 
rectangular reactor occurred in the z direction.   
Rectangular reactor
 
Figure 32. Shear stresses within the porous structure for the case with 85 µm pore 
size and 120 pores/mm2. Arrows indicate the flow direction. 
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5.3.5.  Effect of changing porosity.   
During the course of tissue remodeling, cells will proliferate and de novo synthesize 
extracellular matrix elements which are deposited in the porous structures.  These 
processes reduce the pore space available for fluid flow.  Hence the pore size decreases 
but the number of pores per area does not.  To understand the implications of these 
dynamic changes, simulations were carried out with six decreasing pore sizes (Table 4) 
but using the number of pores per unit area that was determined experimentally (120 
pores/mm2).  These results showed significant increase in the pressure drop across the 
bed with decreased pore size.   
5.4.  DISCUSSION. 
In this study, simulations and experimental validation were performed with and 
without porous structures to understand the fluid flow distribution within the bioreactor.  
The rectangular reactor used in this study has been widely utilized in various studies 
including long term bone marrow cultures 345, athereosclerosis and endothelial function 5, 
homing and rolling of immune cells and liver-assist bioreactor 346, 347.  The reactor 
systems used have distinct advantages for regenerating large clinically transplantable 
tissues such as cartilage, bladder and skin; scaffolds can have very large surface area to 
volume ratios with very small thickness.  Another popular bioreactor configuration 
involves growing cell seeded constructs in microgravity 348.  However, for growing large 
aspect ratio tissues, microgravity reactor would deform the structure due to bending and 
rolling while tumbling through the growth medium, creating a random stress pattern 
within the developing material.  Hence, microgravity reactors may not be suitable for 
regenerating thin cross-sectional tissues.  The parallel plate reactors provide stability and 
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support for the porous structure and developing tissue.   
Further, the experimental results showed compression of the porous structure at 
20 mL/min flowrates.  The compression can be attributed to the mechanical properties of 
the chitosan porous structure (elastic modulus is 2-6 kPa).  To minimize the compressive 
damage on the porous structure, flow rate was reduced to 5 mL/min.  However, in the 
simulation results, these compressive changes were not considered and the porous 
medium was treated as a rigid matrix.  Hence, further studies in which the elastic 
properties of the porous structure are coupled to the fluid force are necessary to better 
understand the fluid distribution.    
Understanding pressure drop changes is important to determine the pressure to be 
maintained during tissue regeneration 349.  To mimic tissue regeneration process, the 
number of pores was kept constant while decreasing the pore size.  The exponential 
increase in pressure drop as pore sizes shrink indicates that liquid flow through a porous 
scaffold will decrease and possibly stop unless flow system is adjusted to provide large 
pressure gradients.  The nonlinear properties of both shear stress distributions and 
pressure drop suggest that there is room for optimization of the porous structure.  Others 
have reported the effect of changing porous structure due to cell growth on the growth 
media distribution in cylindrical scaffolds 338.  These studies used porosity based 
permeability values, which could change by either decreased number of pores or 
decreased the pore size.  Hence, it may not reflect the true regeneration characteristics.   
While the scaffold is subjected to the bulk forces supplied by the tissue and fluid 
flow, the cells experience the micromechanical properties of the individual fibers and 
local shear stresses within the porous structure.  Flow within the reactor determines the 
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orientation of cells within the material.  Shear stresses generated by the fluid motion 
influence alignment of endothelial cells 5 and chondrocytes 125 grown in the parallel plate 
reactor.  Alignment of cells and the de novo synthesized matrix elements determine the 
ultimate quality of the regenerated tissue.  We evaluated the shear stresses within the 
porous structure through simulations.  Shear stress in the porous structures are less 
compared to the estimated wall shear stresses 350.  The shear stress in the porous structure 
is ~ 0 - 0.05 dynes/cm2 in the rectangular reactorA microgravity reactor rotating at 10 
rpm has an average wall shear stress of 0.2 dyne/cm2 and a maximum shear stress of 0.3 
dyne/cm2 123, comparable to parallel plate bioreactors.  However, the tumbling free fall 
motion of the scaffolds produces a non-uniform stress distribution.  Another method uses 
mechanical action to stretch or compress the scaffold material 351, 352.  One configuration 
utilizes screw driven actuators to impart bidirectional stresses to the material 124.  Further 
studies are necessary to determine the optimal method or methods for controlling the 
mechanical forces acting on material within bioreactors 353.  Cellular constructs grown in 
vitro shrink, possibly as a result of cellular attachment and contraction or as a result of 
hydrodynamic forces compressing the scaffold.   
Non-ideal fluid flow patterns lead to non-uniform distribution of nutrients present 
in the fluid.  The RTD analysis is independent of the metabolic reactions and hence 
nutrient consumption is not integrated into the CFD modeling.  To understand the 
implications of non-ideal flow on tissue regeneration, nutrient transfer characteristics 
have to be analyzed.  Nutrient transport and consumption can be investigated through use 
of the reactions package.  Flow rates must be optimized based on i) nutrient distribution, 
ii) effect on assembly of matrix elements, and iii) cellular response to local shear stress.   
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Chapter 6 
Modeling Oxygen Transport within Porous Matrices
6.1. Introduction 
As described in the previous chapter, bioreactors are used to encourage 3D cell 
growth and colonization by using a direct perfusion system to supply a continuous flow 
of nutrients.   The upper limit for the perfusion rate is set by the tolerance of cells to shear 
effects induced by the flowing fluid.  The lower limit is set by the metabolic demand for 
nutrients of each cell type.  The flowrate through the reactor controls the concentration of 
nutrients such as oxygen and glucose.  Therefore, by studying both the flow properties 
through the porous matrix and consumption of nutrients within the system an upper and 
lower range can be determined for bioreactor optimization. 
One of the main ways cells change their local microenvironment is through 
cellular respiration, the process where cells consume oxygen and nutrients and produce 
carbon dioxide, waste, and energy.  One cause of failure in tissue engineering structures 
is hypoxia, a lack of oxygen in the center of the scaffold.  Before new microvasculature 
has formed, cells within the scaffold are dependent upon the flow and diffusion of 
oxygen for survival.  Therefore it is important to study the oxygen transport across the 
scaffold.  Further, glucose was used because of its importance in cellular metabolism.  
Glucose is used as a cellular energy source and plays a central role in various disease 
states such as diabetes354.   
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In order to combat this problem, the role of oxygen transport has been explored in 
a variety of bioreactor configurations.  There are  several ways to experimentally monitor 
the dissolved oxygen level in the fluid using either fluorescence quenching355, 356 or 
electrochemical reduction357, 358.  Work has also been done simulating cell growth in gas 
sparged and agitated vessels that do not contain porous structures359.  Shear stresses have 
also been investigated both computationally and experimentally using parallel plate 
bioreactors with micron scale surface topography360.  Both consumption of oxygen and 
shear stresses for bone tissue engineering have been explored as a 2D computational 
model361.  The concentration of oxygen in rotating wall vessels which utilize nonporous 
micro-carrier beads as cellular supports has also been studied using at a variety of 
conditions 362.  Other models have been developed to study the cell population dynamics 
and oxygen consumption within porous matrices.  However, the population models do 
not account for the effect of fluid flow and shear stress in directing cellular growth and 
attachment, or changes in the 3D porous structure due to cell proliferation, extracellular 
matrix production, and matrix turnover363, 364.  The main drawback to these studies is that 
they use small structures with limited porosity.  Currently there is limited understanding 
of the transport phenomena in large porous structures with a high aspect ratio. 
It is important to understand the processes that occur within the porous matrix as 
the tissue regenerates.  Understanding the regeneration process is especially important in 
high aspect ratio reactors, similar to configurations described in Chapter 5.   The goal of 
this work is to determine a minimum flowrate required to provide adequate nutrients to 
the cells seeded within the porous matrix housed in the parallel plate reactor.  Therefore, 
the effects of cellular metabolism on both oxygen and glucose concentrations within the 
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matrix were added to the simulations developed in Chapter 5.  While performing 
simulations, metabolic consumption for both oxygen and glucose was included using 
kinetic rate laws.  The rate law was defined in the COMSOL simulation, enabling the 
visualization of both the oxygen and glucose profiles within the porous structure.  
Additionally, the simulation data was used to determine appropriate flowrate for an 
optical profiler system, developed in-house to visualize oxygen profile across the 
bioreactor.  These results show different minimum flow rates for different cell types and 
the potential use of oxygen profiler. 
6.2 Materials and Methods 
6.2.1.  Sources of Materials 
Chitosan with >310 kDa MW and 85% degree of deacetylation, glucose, sodium 
bicarbonate,  Dulbecco’s modified Eagle medium (DMEM), and glacial acetic acid were 
obtained from Sigma Aldrich Chemical Co (St. Louis, MO).  Ethanol (200 proof) was 
obtained from Aaper Alcohol and Chemical Company (Shelbyville, KY).  Human 
foreskin fibroblasts (referred to as HFF-1 cell line) were purchased from American 
Tissue Culture Collection (Walkersville, MD).  L-glutamine, penicillin-streptomycin, 
amphotericin, trypsin/EDTA, and Fetal Bovine Serum (FBS) were purchased from 
Invitrogen Corp. (Carlsbad, CA).  All other reagents were purchased from Fisher 
Scientific (Waltham, MA). 
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6.2.2. Simulation nutrient distributions 
The consumption of oxygen was simulated using the COMSOL Multiphysics 
software.  The reaction was added to the simulation by adding a 3D convective diffusion 
model to the Brinkman model already in place (Equation 14).  The convective diffusion 
equation was used to obtain the concentration at varying position along the cross section 
of the reaction: 
( ) ArcucD =∇•+∇−•∇       (22) 
where c is the concentration of the species, rA is the rate of reaction, D is the diffusivity 
of the species, and u is velocity.  Additionally, the fluid system was split into multiple 
parts using two dependent variables in the convective diffusion model.  The rate of 
reaction could then be entered using the reaction rate tab in the subdomain setting of the 
convective diffusion model.  A Michaelis-Menten rate law was used for both oxygen and 
glucose consumption based on the reaction rates reported in the literature 340, 365-367.  The 
rate law is given by the expression 
Am
AMax
A CK
CV
r
+
=−        (23) 
where rA is the rate of reaction, VMax is the maximum reaction rate, and Km is the 
Michaelis constant.  Tow cell types, chondrocytes and smooth muscle cells (SMCs) were 
evaluated using rate constants shown in the Table 5. 
Table 5. VMax and Km valuse for different cell types. 
Cell Type VMax (mol/m3s) Km (mol/m3) 
chondrocytes365 2.47 × 10-6 6.00 × 10-3 
SMCs366, 367 3.16 × 10-5 0.205 
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Flowrates between 0.01 mL/min and 0.001 mL/min were simulated to determine the 
appropriate flowrate where a difference in signal may be measurable experimentally.  
The effect of changing the porous architecture was analyzed similar to Chapter 5, using 
pore diameter and pores/area values from Table 4.  Both the pressure drop and shear 
stress were also evaluated in the reacting simulations.  Additionally, the effect of 
increasing the cell population on oxygen consumption was evaluated using smooth 
muscle cell.  For this purpose, the simulation was performed by using a rate law 
multiplied by 2 and 4 times that of the original rate law as shown below.  
Am
AMax
A CK
CV
r
+
=−
2
       (24) 
Am
AMax
A CK
CV
r
+
=−
4
       (25) 
These simulations were performed at two different pore sizes with the same number of 
pores.  Only one flow rate was used per cell type.  In order to quantify the change in 
oxygen concentration, exiting oxygen content was assessed.   
6.2.4 Cell culture 
Human foreskin fibroblasts (HFF-1), from American Tissue Culture Collection 
(Walkersville, MD), were maintained in Dulbecco's modified Eagle's medium (DMEM) 
supplemented with 4 mM glutamine, 4.5 g/L glucose, 1.5 g/L sodium bicarbonate, 100 
U/mL penicillin-streptomycin, 2.5 mg/mL amphotericin B, and 20% fetal bovine serum 
(FBS).  Cells were maintained at 37ºC, in a 5% CO2/95% air and fed with fresh medium 
every 48 h.  Cells were dissociated with 0.01% trypsin / 10 mM EDTA, centrifuged, and 
resuspended in medium prior to cell seeding. 
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Cell culture procedure for the reactor experiments is shown in Figure 33.  In 
brief, chitosan porous structures were prepared by pouring 20mL of 0.5% (wt/v) chitosan 
solution with 0.7% (v/v) acetic acid into the Teflon silicon well system described 
preciously16, freezing at -80ºC, and lyophilizing overnight.  Samples were cut into 2.5 cm 
× 8 cm, sterilized with ethanol, rinsed twice with PBS, and placed into a sterile Petri dish.  
Cell growth media was added, and the scaffolds were then seeded with 450 cells/mm2 (9 
× 105 cells/scaffold), three times more than used in previous experiments 5, 231.  The cells 
were allowed to attach and colonize the scaffold overnight, and then used for reactor 
experiments.   
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Figure 33. Cell culture technique used with the optical profiler 
6.2.3.  Constructing an optical profiler 
The oxygen profile was visualized using an optics system developed in house.   
The optical profiling system is based on a glass slide coated with an oxygen sensitive 
material, Tris(4,7-diphenyl-1,10-phenanthroline)ruthenium(II) chloride356, purchased 
from Ocean Optics (Dunedin, FL).  The ruthenium based coating is encapsulated in a sol 
gel matrix and thereby protected from the environment.  The coating absorbs light at 470 
nm (blue) and has an emission peak between 500nm and 600 nm (green to yellow).  The 
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dissolved oxygen level in the media can then be determined because the fluorescence is 
dynamically quenched by oxygen.  Therefore, more fluorescent signal should correlate to 
less oxygen present in the media368.  The glass slide is placed in a recessed area of the 
bioreactor as shown in Figure 34.  This recess allows the slide to contact the fluid flow 
area while maintaining a uniform height for the bottom plate of the reactor. 
 
 
Figure 34. Coated glass slide inserted into reactor. 
 
The reactor is then placed into an optics system shown in Figure 35.  The system 
is supported on a system of interconnected round bar, and uses a 250 W Utilitech™ 
halogen work light (Purchased from Lowe’s Home Improvement) as a light source.  Light 
is funneled from the work light into a sealed black metal container using reflective 
aluminum ducting, commonly used in clothing dryer vents.  As the light enters the sealed 
box containing the reactor it passes through a blue emmission filter (Science Kit and 
Boreal Laboratories, Tonawanda, New York).  The blue light excites the oxygen sensor 
and which emits fluorescence at 600nm wavelength.  Next both the blue light and 
fluorescent emissions travel down an optical tube originally designed for a Spencer 
Spectrographic Camera (circa 1938)369.  As the light exits the objective lens of the old 
camera optics it passes through a 515 nm excitation filter (Ocean Optics, Dunedin, FL) in 
 
Coated Slide 
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order to remove any remaining lower wavelengths, while still retaining the entire 
fluorescent emission spectra.  The 515nm filter sits on a 90º mirror that fits nicely on the 
digital camera lens.  The mirror redirects the fluorescent signal into a digital camera 
(Canon Powershot 550, Canon U.S.A., Lake Success, New York) so it can be visualized 
and recorded.  For samples containing cells, first a 2 cm × 8 cm × 0.2 cm section of 
porous chitosan was prepared by freezing 0.5% chitosan at -80ºC and lyophilizing 
overnight.  The scaffolds were then seeded with 450 cells/mm2 (9 × 105 cells/scaffold), 
three times more then used in previous experiments 5, 231.  The reactor was then sterilized 
with ethanol, and the cell seeded scaffolds were loaded into the reactor.  The reactor was 
then placed into the optics system and images were captured every 10 minutes for 1 hour 
using a flowrate of 0.05 mL/min.  Next, the flowrate was lowered to 0.005 mL/min and 
images were captures every 10 minutes for another hour.  To obtain such a low flowrate, 
0.19mm ID microbore (Masterflex,) tubing was used.  The microbore tubing was 
attached to the reactor inlet using silicon glue.  Additionally, in order to reduce the 
amount oxygen leaking into the system, experiments were performed in an anaerobic 
chamber that had been purged with nitrogen three times. 
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Figure 35. Diagram and photograph of the optics system. 
6.3 Results 
6.3.1. Simulating oxygen profile 
Computational simulations were performed in order to determine the appropriate 
flowrates such that it might be possible to detect a signal from the oxygen profiling 
apparatus.  COMSOL simulations were created using both oxygen and glucose rate law 
data for both smooth muscle cell and chondrocytes.  Both sets of simulations were 
performed at the same cell density (1.2 × 1012 cells/m3).  These results showed (Figure 
36) that flowrate between 0.001 mL/min and 0.005 mL/min may have measurable oxygen 
profiles for chondrocytes, and flowrate between 0.01 mL/min and 0.05 mL/min may have 
measurable oxygen profiles for SMCs.  The simulations also show that both oxygen and 
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glucose consumption is lower in smooth muscle cells than in chondrocytes (Figure 37).  
The results also show that there is a difference between oxygen and glucose consumption 
for both cell types.  Additionally, the difference in oxygen and glucose consumption is 
higher in SMCs than in chondrocytes. 
 
Figure 36.  Simulated oxygen profiles for the rectangular reactor 
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Figure 37. Simulated glucose profiles for the rectangular reactor 
 
6.3.2. Effect of reaction on pressure drop and shear stress. 
 The pressure drop and shear stress within the reactor were measured using an 85 
µm pore diameter and 120 pores/mm2 (ĸ = 154 µm2) at a variety of flowrates (Table 6). 
These results show that both the pressure drop and max shear stress vary linearly with the 
flowrate.  Additionally, for each flowrate the pressure drop and shear stress are identical 
for both cell types.  The identical pressure drop and shear stress numbers show that they 
are controlled by the Brinkman equation and not affected by the convective diffusion 
model that contain the reaction rate law.  Additionally, the values for shear stress and 
pressure drop did not change when the simulation was run without the reaction (rate = 0). 
 
0.001 mL/min 0.003 mL/min 0.005 mL/min 
Chondrocytes 
Smooth Muscle Cells  
0.01 mL/min 0.03 mL/min 0.05 mL/min 
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Table 6.  Pressure drop and shear stress within the reaction simulations at a variety of different 
flowrates. 
Chondrocyte SMC Flowrate 
(mL/min) 
 
Pressure 
Drop (Pa) 
Maximum Shear 
Stress (Pa) 
Pressure Drop 
(Pa) 
Maximum Shear 
Stress (Pa) 
0.001 0.126 4.77×10-6 0.126 4.77×10-6 
0.002 0.253 9.54×10-6   
0.003 0.378 1.43×10-5   
0.0035 0.441 1.67×10-5   
0.004 0.504 1.91×10-5   
0.005 0.631 2.39×10-5   
0.01 1.26 4.77×10-5 1.26 4.77×10-5 
0.02   2.52 9.54×10-5 
0.03   3.79 1.43×10-4 
0.04   5.04 1.91×10-4 
0.05   6.31 2.39×10-4 
1 126 4.77×10-3 126 4.77×10-3 
5 631 0.0237 631 0.0237 
6.3.3.  Effect of changing pore size on reaction 
Next the effect of changing pore size within the reacting system was analyzed, 
similar to Chapter 5.  The effect of changing pore size in the cellular system was 
simulated using smooth muscle cells and a 0.05 mL/min flowrate.  Once again nonlinear 
behavior is seen in both the pressure drop and shear stress (Table 7).  Additionally, the 
reaction is not affected by changing the pore size. 
Table 7.  Effect on pressure drop and shear stress in reacting systems as pore size is 
decreased. 
Pore 
Size 
(µm) 
Pores/
mm2 
 
k 
(µm2) 
 
Pressure 
Drop 
(Pa) 
Maximum 
Shear Stress 
(Pa) 
Minimum Oxygen 
Concentration 
(mol/m3) 
85 120 154 6.31 2.39×10-4 0.125 
50 120 18.4 52.6 2.46×10-4 0.125 
37.5 120 5.82 166 2.47×10-4 0.125 
25 120 1.15 842 2.48×10-4 0.125 
17.5 120 0.276 3510 2.48×10-4 0.125 
10 120 0.0295 32800 2.48×10-4 0.125 
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6.3.4.  Effect of changing the number of cells 
The number of cells was changed in the experiment using a cell multiplier.  By 
including the multiplier in the rate law calculation it is possible to simulate the effect of 
doubling or quadrupling the number of cells present in the matrix.  Therefore the effect of 
increasing the cells within the reactor was explored using smooth muscle cells and a 0.05 
mL/min flowrate.  As shown in Table 8 and Figure 38, the oxygen concentration at the 
exit of the porous structure decreased with the increase in the number of cells, and the 
pressure drop and shear stress were not affected.  Additionally, the oxygen concentration 
was affected only by the changing the number of cells.  As expected this shows that the 
oxygen concentration is controlled by the convective diffusion model, while shear stress 
and pressure drop are controlled by the Brinkman equation. 
Table 8.  Outlet oxygen concentration decreases as the number of cells increases. 
Cell 
Multiplier 
 
Pore 
Size 
(µm) 
Pores/
mm2 
 
k 
(µm2) 
 
Pressure 
Drop 
(Pa) 
Maximum 
Shear Stress 
(Pa) 
Minimum Oxygen 
Concentration 
(mol/m3) 
1x 85 120 154 6.31 2.39×10-4 0.125 
2x 85 120 154 6.31 2.39×10-4 0.071 
4× 85 120 154 6.31 2.39×10-4 0.018 
1× 25 120 1.15 842 2.48×10-4 0.125 
2× 25 120 1.15 842 2.48×10-4 0.071 
4× 25 120 1.15 842 2.48×10-4 0.018 
 
 
Figure 38.  Effect of increasing the number of cells present in the simulation. 
1× Cells 2× Cells 4× Cells 
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6.3.5.  Experimental visualization of the oxygen profile 
The optical profiler system offers a new method for viewing the flow profile 
across the porous matrix (Figure 39).  Experiments were carried out at both 0.05 ml/min 
and 0.005 mL/min flowrates.  First the experiment was run with unseeded chitosan 
scaffolds in order to get a base reading for the experimental setup.  Next a cell seeded 
matrix was used as a packing material.  All three results clearly show the physical 
features of the porous matrix including areas which are more densely packed and air 
bubbles contained within the material (Figure 39).  However, further research is needed 
in order to increase the sensitivity of the system.  Possibly reasons for lower sensitivity 
could be the sensitivity and resolution of the digital camera, non-uniform distribution of 
lighting (causing bright spots), long wavelengths of light leaking past the blue filter, or a 
final filter with too low a wavelength cutoff.  Low cell concentration is another possible 
reason the optical profiler.  Therefore, future experiments should use a higher cell count 
and double check the viability cells after use in the reactor.  More research is needed to 
modify the existing setup in order to increase the amount of useful data obtained from the 
optical profiler, possibly including exchanging the digital camera for a 
spectrophotometer, replacing existing light source with a bank of blue LEDs, or using 
microelectrodes to measure the oxygen distribution at the inlet and outlet of the reactor. 
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Figure 39. Fluorescent images from bioreactor in the optical system. 
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6.4. Discussion 
One of the key goals to this work is to determine a minimum flowrate required to 
ensure proper nutrient flow to cells within parallel plate direct perfusion reactors.  As 
such, two very different cell types (chondrocytes and smooth muscle cells) were analyzed 
via simulation.  Chondrocytes are the cells primarily responsible for producing cartilage, 
an avascular tissue whose function is to provide cushioning and lubrication at joints.  
Smooth muscle cells expand and contract to ensure involuntary movement within the 
body.  Because of their functions within the body chondrocytes are far from the blood 
supply while smooth muscle cells are near the blood stream.  As expected the simulation 
data confirms that chondrocytes consumed oxygen and glucose slower than smooth 
muscle cells, and that the minimum flowrate required for smooth muscle cells is an order 
of magnitude higher than for chondrocytes.   
 Another issue of interest is whether the reaction and flow properties are coupled 
together.  In real tissues when cells multiply the new cells both demand nutrients and take 
up space.  Therefore cell growth will change the demand for oxygen and nutrients as well 
as the pore size and void fraction of the porous structure.  However, the simulation is 
controlled by the permeability, void fraction, and the rate law for the consumption of 
oxygen.  This work has shown that the permeability of the matrix controls both the 
pressure drop and shear stress, and the reaction rate controls the oxygen and glucose 
distribution across the reactor. 
One of the limitations to the current model is that change in permeability, void 
fraction, and rate of oxygen consumption are treated as completely independent 
phenomena.  However, these are interdependent factors which dynamically change 
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during tissue regeneration.  Therefore, future work should focus on providing a better 
understanding of the microscale phenomena that occur during tissue regeneration in order 
to better couple the changes in reaction rate to changes in the porous structure as cells 
colonize the scaffold material.   
Because different finite element mesh sizes were used for Chapter 5 and Chapter 
6, the Chapter 6 simulation data was similar but not identical to the Chapter 5 data.  For 
example structures 85µm pore diameter, 120 pores/mm2, and a 5mL/min flowrate the 
simulations developed for Chapter 5 give a pressure drop of 0.57 kPa while simulations 
developed for Chapter 6 give a pressure drop as 0.63 kPa.  This difference is a result of 
computational error and shows the importance of the meshing technique and mesh size in 
finite element analysis.  The importance of the meshing technique can also be seen in a 
cross sectional analysis of the results.  Figure 40 shows both the surface mesh and 
velocity field in the porous subdomain for both Chapter 5 and Chapter 6.  Simulations 
including the chemical reaction would not solve using the Chapter 5.  So a coarser mesh 
was used in Chapter 6 in order to reduce the computational load of the simulations.  As 
expected the finer mesh used in Chapter 5 provides a more uniform velocity field then the 
course mesh from Chapter 6.  Therefore, the effects of mesh size on the flow and reaction 
properties of the simulation should be monitored in future work. 
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Figure 40. Surface Meshes and Velocity fields for Chapter 5 and Chapter 6, 85 µm pores, 120 
pores/mm2, 5 mL/min 
Additionally, the simulation results were used as a basis to perform experiments 
and use the optical profiler system.  Using flowrates between 0.01 and 0.001 mL/min the 
scaffold should generate a twofold difference in dissolved oxygen concentration across 
the reactor.  However, the profiler was not able to detect that difference.  This could be 
Future work, including the use of spectrophotometry or improvements to the existing 
optics, is required before the profiler will be a valid method for viewing the oxygen 
profile through a bioreactor system. 
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Chapter 7 
Summary and Future Work
7.1. Summary 
Tissue engineering is a field that seeks to provide materials to help alleviate the 
transplant crisis by regenerating damaged or diseased tissue using biodegradable 
materials.  In brief, the damaged tissue is removed and replaced by a porous tissue 
scaffold.  Over the course of regeneration, cells grow into the scaffolding and the material 
degrades away, eventually leaving only normal healthy tissue.  Current clinical practice 
for tissue engineering uses natural matrices, such as small intestinal submucosa (SIS) 
which has seen partial success.  However, the heterogeneous nature of natural materials 
leads to inconsistent tissue regeneration.  Therefore polymer matrices are used in order to 
create scaffolds with consistent properties.  Currently, there is no single material that will 
satisfy both the structural and biological requirements for tissue engineering.  There are 
several methods for designing new scaffolding materials.  Materials for tissue 
regeneration can be improved by either focusing on the synthesis of novel biomaterial or 
by blending existing biomaterials with required composition.  My strategies focus on 
blending biomaterials to develop materials structures mimicking natural materials 
clinically utilized in few selected regeneration applications.  The goal of this reverse 
engineering principle is to address fundamental design principles necessary for tissue 
regeneration strategies.   
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As such a multilayer composite material has successfully been developed 
combining both natural and synthetic polymer systems.  The composite is fabricated in a 
mechanically interlocked 3 layer sandwich configuration.  The two outer layers are made 
from porous chitosan and provide biological activity, and the inner layer is PLGA, 
providing mechanical strength257.  The mechanical and degradation are similar to SIS, 
and the composite material supports the colonization and proliferation of cells16.  
Additionally, the mechanical properties can be tailored by modifying the molecular 
weight of the PLGA independent of the biological properties of the chitosan layer.  The 
next step in the research is improving the material.  The improvements made focus on 
studying mass transfer properties at both the local and global scale in order to better 
model the biological properties of SIS and to help improve in vitro regeneration when the 
cell seeded material is matured in a bioreactor system. 
Specific Aim 1.   
A nanoparticle system was developed in order to better control the local mass 
transport properties in the porous matrix.  A variety of nanoparticles (PLGA, PLGA-HA, 
polystyrene latex, and chitosan were successfully integrated into both the composite 
matrix and SIS.  In the particles were visible on both sides of the SIS, showing that the 
particles were embedded in the material.  Additionally, the mass transport properties of 
SIS were successfully modified using the nanoparticles.  The permeability of SIS to urea 
was reduced by the presence of nanoparticles, and the permeability is a function of both 
the size and number of nanoparticles present. 
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Specific Aim 2:   
Engineered tissue can be matured in in vitro bioreactors before implantation.  
Non-ideal flow problems, such as poor nutrient distribution and variable mechanical 
forces, become more pronounced in large scale, high aspect ratio materials that are 
required for bladder, blood vessel, or articular cartilage applications.  Therefore, the 
effects of flow distribution through the porous matrix were also investigated.  First, the 
flow dynamics, characterized by residence time distribution (RTD), in a parallel plate 
reactor with no porous structure present were successfully simulated in the computational 
fluid dynamics (CFD) software CFX.  The RTD was then successfully validated using a 
bench top reactor and a colored dye tracer, and b calculating an analytical solution.  
Additionally, RTD experiments utilizing the porous chitosan material provided insight 
into the effect of the porous structure on the flow distribution within the material.  Next, 
the effect of changes in the porous structure, as a result of both scaffold fabrication and 
cellular ingrowth, on flow distribution, pressure drop, and shear stress within the matrix 
were successfully simulated using COMSOL Multiphysics.  The simulations including 
the porous matrix were then validated using a benchtop reactor. 
Specific Aim 3. 
The effect of cellular metabolism was included into the simulation.  Both the 
concentration of oxygen and glucose were integrated into the simulation using a 
Michaelis-Menten rate law.  Simulations were performed using data from both 
chondrocytes and smooth muscle cells, showing that a flowrate between 0.01 mL/s and 
0.001mL/s gives a profile across the reactor with a twofold difference in oxygen 
concentration.  Further, an optics system was created in order to attempt to visualize the 
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oxygen profile across the reactor.  However, further research is required to make the 
optical profiler a viable method for measuring the oxygen concentration across a reactor 
system. 
7.2. Future Work 
While these developments have helped to improve polymer tissue engineering 
materials there is still room for improvement.  One goal is to enable the intelligent design 
of scaffold materials tailored to each specific clinical need.  A better understanding for 
the fundamental processes during tissue regeneration is needed in addition to 
improvements to the tailorability of existing materials.   
 
7.2.1. Nanoparticle delivery of heterogeneous cellular signals.    
As mentioned previously, most biomaterials research focuses of one aspect of 
tissue regeneration to the exclusion of others.  During my graduate work I focused on 
improving the structural properties of tissue engineering materials.  However the 
biological properties of the scaffolding must also improved.  Cells receive biological 
signals from a variety of molecules.  Some, like growth factors, have very short (minutes 
to hours) half lives in solution.  Therefore in order to better utilize these signals they must 
be protected from denaturation and released in a controlled manner.  One release method 
uses micro and nano-particles for controlled release of bioactive molecules.  The field of 
drug delivery tends to focus on the homogeneous sustained release of the molecule of 
interest.  However, human tissue is a heterogeneous material, containing different cell 
types and materials.  Therefore heterogeneous signaling is required for optimal 
regeneration using tissue engineering materials.  Additionally, nanometer size particles 
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are uptaken by the cells, enabling both the intracellular and extracellular delivery of 
active biomolecules within the tissue construct.  The nano sized particles are also 
important because most cells have a diameter of roughly 10 µm.  Therefore the nano size 
is required in order to send heterogeneous signals to a single cell.  Another advantage of 
using particles is that they can be created from a large group of materials, be fabricated 
over multiple size ranges, and be distributed in a variety of manners.  Therefore it is 
should be possible to achieve both homogeneous and heterogeneous release behaviors.  
By modifying the size, location, and concentration of particles within the material it 
should be possible to form sustained concentration gradients within the material, and by 
using multiple sets of particles loaded with different bioagents it is possible to regenerate 
complex tissue structures containing multiple cell types.  Additionally, the presence of 
nanoparticles can be used to further tailor the transport properties within the scaffold 
material.   
7.2.2. Complex scaffold architecture mimicking anatomical structures.   
One inherent weakness in the current fabrication techniques for porous tissue 
scaffolds is their simple structures, typically either planar sheets or small cylinders.  
However, tissues in the body come in a variety of geometries.  For example the bladder is 
a hollow spherical structure, blood vessels are cylindrical.  Additionally, both bladder and 
blood vessels have a multilayer asymmetric architecture.  While some fabrication 
schemes like those that rely on photolithography are planar in nature, several other 
techniques such as wet spinning, electrospinning, controlled rate freezing and 
lyophilization, and rapid prototyping could be adapted to form hollow 3D scaffold 
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material suitable for clinical use.  Additionally, the composite system could be used to 
create a layered asymmetric structure similar to native tissue.   
7.2.3. Mechanotransduction in bioreactor engineering.   
The effect of stress on tissue regeneration is another area that has not been fully 
explored in the context of tissue engineering.  Both physical stresses and fluid shear 
stress affect the colonization, alignment, and extracellular matrix production of a variety 
of cells grown on 3D tissue scaffolds, from endothelial cells and smooth muscle cells 
(blood vessels) to chondrocytes (cartilage).  Therefore, the forces in and around the 
scaffold material affect the quality of regenerated tissue  There are several methods 
available to directly place stresses on scaffold materials.  Two methods are currently used 
to generate stresses with the scaffold material.  Hydraulic shear stress can be controlled 
using fluid flow within the reactor, or mechanical stresses can be added by deforming the 
stretching or compressing the material.  Therefore a comparison study of these two 
mechanisms for mechanotransduction should lead to improved quality of regenerated 
tissue, as well as helping elucidate the fundamental effects of mechanical stimulus upon 
regenerating tissue.   
7.2.4. Improving reactor simulations and the optical profiler system.   
Both the reactor simulations and the optical profiler show promise in providing a better 
understanding of nuteirnt transport within the system.  One way to improve the data 
generated by simulations is to provide better models for the porous structure.   Currently, 
the simulation uses the Brinkman equations (which assume a symmetric spherical pore 
system) to model transport through the porous structure.  In reality the porous matrix is 
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not symmetric and the pores are not spherical.  Therefore, it would be beneficial to 
measure the actual porous structure by micro-computer tomography (µ-CT) and then use 
that data to build the mesh in the porous region.  With µ-CT t is also possible to measure 
cell seeded matrices and determine how the porous structure and the porosity change as 
cells colonize the material.  Additionally, by altering the µ-CT settings it is possible to 
differentiate between matrix and cells, giving a 3D representation for the cell density on 
all areas of the scaffold.  The main drawbacks to µ-ct imaging are that it has only a 10 
µm resolution and it is difficult to get high quality pictures of soft materials, other options 
for determining how cell colonization changes the porous structure incluse both histology 
and environmental SEM.  Another important step in simuation work is experimental 
validation.  Therefore, future work should also attempt to validate the simulations using 
electrochemical dissolved oxygen probes.  The cellular tolerance for hypoxia within the 
parallel plate reactor is not well understood, and with validation equipment in place a 
more accurate lower bound on the flowrate may be determined. 
 A possible reason for the optical profiler not to show a measurable signal could be 
attributed to low a number of cells used in the experiments.  Hence, experiments have to 
be performed with increased cell number, similar to the numbers used in simulation.  In 
addition, the experiments should use a cell type similar to the simulation (e.g. SMCs).  
Experiments using a higher cell number may provide a measurable signal.  Future 
experiments should also check the viability of cell seeded matrices after they are used in 
the optical profiler. 
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Appendix 1 
A.1: Mathematical Derivations. 
The RTD function for an ideal completed developed laminar flow with no slip at 
the boundaries can be derived by the method described in Fogler340.  The reactor was 
modeled as a set of parallel plates with a width (w) and a height (h) as described in 
Truskey et al 344.  For the ideal case, side and end effects are ignored leaving a laminar 
flow profile only in the y-direction.  Therefore, the velocity in the z-direction can be 
calculated from the volumetric flowrate. 
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Next the required for a fluid particle to travel in the z direction is calculated. 
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Next the volume fraction of total fluid passing between y and y + dy, 
0v
dv
,  and the 
fraction spending between time between t and dt in the reactor were calculated. 
  
000 v
wyV
v
v
v
dv Z=∆=       (A.7) 
  
0
)(
v
dvdttE =         (A.8) 
  wdy
v
VdttE Z
0
)( =        (A.9) 
Eq. (A.8) was differentiated in order to replace the dt term. 
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The dt value was then substituted into Eq. (A.9). 
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The equation is further simplified by substituting in t2. 
  
yt
h
tE 3
2
12
)( τ=        (A.12) 
Further, from Eq. (A.8). 
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The final RTD expression is 
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Finally the minimum residence time is calculated from the maximum velocity. 
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Eq. (A.16) and Eq.(A.17) were used to generate E(t) curves for the ideal conditions. 
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Appendix 2 
A.2. CFX Walkthrough
This is a walkthrough for creating a simulation of liquid flowing through a tubular reactor 
where a tracer is added as a step change at time zero and the simulation is run until the 
reactor contains 100% tracer 
Building and running a CFX model  
Open CFX 
Create a working directory 
- working directory should not be located on desktop or contain spaces. 
Start CAD2Mesh (ANSYS workbench) 
 
CAD2Mesh 
Click on New – Geometry 
Select desired length – Inch 
Select x-y plane 
Select sketching tab 
Select draw – circle 
Draw the circle with a center point at the origin 
Select Dimensions Tab – Diameter 
  152 
Click on circle – specify diameter 
Click on the dimensions box – Enter 6in diameter 
Click Extrude button – set depth = 144in 
Click Generate  
Awe in wonder at the tube you’ve drawn!!! Then save it, and close DesignerModeler! 
From Project screen choose DesignerModeler Tasks – New CFX Mesh 
Go to Model – Geometry – Verify Options – Short Edge Length 
- This is where you set the minimum edge length for the tetrahedral volume elements 
Go to Mesh – Spacing – Default Body Spacing – Maximum Spacing 
- This is where you set the maximum edge length for body spacing 
Go to Mesh – Spacing – Default face Spacing – Minimum Edge Length 
- This is where you set the minimum edge length for face spacing 
Go to Mesh – Spacing – Default face Spacing – Maximum Edge Length 
- This is where you set the amximum edge length for face spacing 
- I like to make this number less then the radius 
Next go to the upper toolbar click on Go – Verify Geometry 
Click on Go – Generate All Surface Meshes 
Click on Go – Generate Volume Mesh 
I like to adjust the edge lengths and spacing until I get 30,000 – 50,000 volume elements 
Save your work, close ANSYS workbence, Start CFX-Pre 
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CFX-Pre 
Making the Tracer 
Click the “Materials” tab 
Scroll down and select Water. 
Click the “Duplicate Selected Objects” button (looks like two sheets of paper connected 
by an arrow) 
Enter Name for duplicate (I used “Tracer”) 
 
Import the Mesh 
Click the mesh tab 
Click the “Import Mesh” button (has a folder with a blue mesh behind it) 
Browse for a new file (click the button that looks like a folder next to the file entry box) 
Open Unnamed.gtm 
Click OK 
Setting up the simulation 
Next you’re going to walk down the buttons at the top of the screen. 
Starting with “Define Simulation Type” (looks like a clock) and ending with “Write 
Definition File.”  First run the simulation in Steady State, then modify it to run in 
transient conditions. 
 
Define Simulation Type 
Select Steady State – Click OK 
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Create a Domain 
Name your domain and click OK 
General Options – Fluids List -  Choose Water and Tracer 
Leave the rest as defaults 
Fluid Models – check “Homogeneous Model” for both Multiphase and Heat transfer 
Model 
Tracer, Water, and Fluid Pairs – use default values 
 
Boundary Conditions 
Create Boundary – Boundary Type - Inlet 
Basic Settings – Location – select the inlet location (click on the arrow and it will let you 
see where the selected boundary is) 
Boundary Details –  
Flow Regime – Subsonic 
Mass and Momentum – Option Bulk mass flow rate (set the mass flow in) 
Flow direction – normal to boundary 
Turbulence – depends on info available (I usually use “default intensity and 
autocompute length scale”) 
 
Fluid Values – Boundary Conditions 
Tracer volume fraction = 0 
Water Volume Fraction = 1 
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Create Boundary – Boundary Type – Outlet 
Basic Settings – Location – select the inlet location (click on the arrow and it will let you 
see where the selected boundary is) 
 
Boundary Details –  
Flow Regime – Subsonic 
Mass and Momentum – Option Bulk mass flow rate (set the mass flow out) 
 
Create Boundary – Boundary Type – Wall 
Basic Settings – Location – select the inlet location (click on the arrow and it will let you 
see where the selected boundary is) 
Boundary Details – No Slip, Smooth wall 
 
Global Initialization 
Global Settings – Check “Turbulent Eddy Dissipation” 
Leave the rest set to defaults 
Fluid Settings –  
Tracer Volume Fraction = 0 
Water Volume Fraction = 1 
 
Solver Control 
Use Defaults 
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Results 
Use either Full or Selected variables (Velocity and tracer volume fraction) 
 
Write Solver File 
Add file name and start solver manager 
 
Solver Manager 
Load your definition file and run solver 
Modifying the Simulation for Transient Flow 
 
First you may want to save your file as a new file, that way you still have the steady state 
file you just ran.  Then modify the following: 
Simulation Type – Basic settings – Option – Transient 
Next set the time duration and timesteps…  I like to set the number of timesteps per run 
and the timestep length 
Example: For the 30mL/s flowrate I used 80 timesteps with 30 second timestep durations 
(giving a total run time of 40 minutes), or I set the time per run and timestep duration (40 
minutes at a 30 second timestep durations is 80 timesteps) 
Physics – Inlet – Change your entering volume fractions to all tracer and no water 
Physics – Global Initialization – Fluid Setting - Change the volume fractions automatic 
Output Control – Transient Results – Create Transient Results File 
The transient results file is what saves your data at each timestep, if you don’t make one 
then only your last timestep data will be recorded. 
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Write a Solver File  
Name the transient definition file something different then the steady state file 
Solver Manager 
Definition file: The Transient definition file 
Initial Values File:  The Steady State results file 
Check Interpolate Initial values onto def file mesh (if you get a mesh doesn’t match error 
check this box) 
Start Run! 
CFX-Post 
Load Results 
Create plane in center of tube (YZ plane at X = 0) 
Create contour plot 
Location: The plane in the center of the tube 
Variable: Tracer.VolumeFraction 
Range: Global 
Now play with the timestep selector (Top menu, looks like a clock) and watch the colors 
move! 
Create plane just before the outlet (XY plane at Z = 143.9 in) 
Using the actual outlet tends to be problematic 
Optional but pretty - Create contour plot 
Location: The plane near the outlet 
Variable: Tracer.VolumeFraction 
Range: Global 
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To export data 
File – Export 
Filename – pick a filename (the file will be written to your working directory unless 
you browse to a different folder) 
Type: Generic 
Locators: Plane near the outlet 
Select Variables: Tracer Velocity, Tracer Volume Fraction 
Save 
Open the .csv file in MS Excel 
 
Taking Pictures 
File - Print 
Format – JPEG 
Filename – this is where it will save the file 
If you want to print it on paper, then check “use white background” 
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